<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">22847</article-id><article-id pub-id-type="doi">10.7554/eLife.22847</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Human cardiac fibroblasts adaptive responses to controlled combined mechanical strain and oxygen changes in vitro</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-72599"><name><surname>Ugolini</surname><given-names>Giovanni Stefano</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4775-6676</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-74093"><name><surname>Pavesi</surname><given-names>Andrea</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2777-1043</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-74717"><name><surname>Rasponi</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-74718"><name><surname>Fiore</surname><given-names>Gianfranco Beniamino</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-19767"><name><surname>Kamm</surname><given-names>Roger</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-72740"><name><surname>Soncini</surname><given-names>Monica</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8607-7196</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Electronics, Information and Bioengineering</institution>, <institution>Politecnico di Milano</institution>, <addr-line><named-content content-type="city">Milan</named-content></addr-line>, <country>Italy</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Institute of Molecular and Cell Biology</institution>, <institution>Agency for Science, Technology and Research</institution>, <addr-line><named-content content-type="city">Singapore</named-content></addr-line>, <country>Singapore</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Biosym IRG</institution>, <institution>Singapore-MIT Alliance for Research and Technology</institution>, <addr-line><named-content content-type="city">Singapore</named-content></addr-line>, <country>Singapore</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Biological Engineering</institution>, <institution>Massachusetts Institute of Technology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Vunjak-Novakovic</surname><given-names>Gordana</given-names></name><role>Reviewing editor</role><aff><institution>Columbia University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><email>monica.soncini@polimi.it</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>18</day><month>03</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>6</volume><elocation-id>e22847</elocation-id><history><date date-type="received"><day>08</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>17</day><month>03</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Ugolini et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Ugolini et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-22847-v3.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.22847.001</object-id><p>Upon cardiac pathological conditions such as ischemia, microenvironmental changes instruct a series of cellular responses that trigger cardiac fibroblasts-mediated tissue adaptation and inflammation. A comprehensive model of how early environmental changes may induce cardiac fibroblasts (CF) pathological responses is far from being elucidated, partly due to the lack of approaches involving complex and simultaneous environmental stimulation. Here, we provide a first analysis of human primary CF behavior by means of a multi-stimulus microdevice for combined application of cyclic mechanical strain and controlled oxygen tension. Our findings elucidate differential human CFs responses to different combinations of the above stimuli. Individual stimuli cause proliferative effects (PHH3<sup>+</sup> mitotic cells, YAP translocation, PDGF secretion) or increase collagen presence. Interestingly, only the combination of hypoxia and a simulated loss of contractility (2% strain) is able to additionally induce increased CF release of inflammatory and pro-fibrotic cytokines and matrix metalloproteinases.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.001">http://dx.doi.org/10.7554/eLife.22847.001</ext-link></p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.22847.002</object-id><title>eLife digest</title><p>When the supply of oxygen to the heart is reduced, its cells start to die within hours, the heart muscle becomes less able to contract, and the area becomes inflamed. This inflammation is accompanied by an influx of immune cells. It also activates other cells known as cardiac fibroblasts that help to break down the framework of molecules that supported the damaged heart tissue and replace it with a scar. This response is part of the normal repair process, but it can lead to the formation of scar tissue in non-damaged areas of the heart. Excess scar tissue makes the heart muscle less able to contract and increases the affected individual’s chance of dying.</p><p>Understanding how this repair process works is an important step in developing strategies to minimise the damage caused by coronary artery disease or heart attacks. However, existing laboratory models are only partly able to recreate the conditions seen in real heart tissue. To properly understand the response at the level of living cells, a more complete model is needed.</p><p>Ugolini et al. now report improvements to a small device, referred to as a lab-on-chip, that can subject cells to mechanical strain. The improvements mean the device could also recreate other conditions seen early on in damaged heart tissue, specifically the reduced supply of oxygen. Replicating combinations of mechanical changes and oxygen supplies meant that the impact of these conditions on human cardiac fibroblasts could be directly observed in the laboratory for the first time. Ugolini et al. found that a lack of contraction and low oxygen levels triggered the cardiac fibroblasts to produce inflammatory molecules and molecules associated with the formation of scar tissue. This resembles the response seen in living hearts.</p><p>The next step is to improve the lab-on-chip device further by adding other cell types, including heart muscle cells and immune cells. A more complete model may aid future research into how our hearts operate in both health and disease.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.002">http://dx.doi.org/10.7554/eLife.22847.002</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author Keywords</title><kwd>cardiac remodeling</kwd><kwd>cardiac fibroblasts</kwd><kwd>pathological modeling</kwd><kwd>organs-on-chip</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research Organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001474</institution-id><institution>Singapore-MIT Alliance for Research and Technology Centre</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kamm</surname><given-names>Roger</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001321</institution-id><institution>National Research Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kamm</surname><given-names>Roger</given-names></name></principal-award-recipient></award-group><funding-statement>No external funding was received for this work.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.5</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Human cardiac fibroblasts regulate their cellular responses according to the combination of multiple environmental stimuli namely oxygen changes and mechanical signals.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>When supply of oxygen and nutrients to the myocardium is critically reduced (ischemia), a complex tissue response takes place: within hours tissue necrosis and death of contractile cardiac myocytes occurs in the infarcted area giving rise to an inflammatory phase that recruits immune cells and activates quiescent cardiac fibroblasts (CFs); within a few days a proliferative phase begins, where activated CFs invade the infarcted area and contribute to degrading and replacing the extra-cellular matrix with a collagen-based scar; within weeks the maturation of the fibrotic scar is completed (<xref ref-type="bibr" rid="bib20">Frangogiannis, 2014</xref>; <xref ref-type="bibr" rid="bib29">Heusch et al., 2014</xref>). Cellular and molecular events such as excessive proliferation of CFs, phenotypic switch of CFs, high levels of inflammatory cytokines and humoral factors, unbalanced synthesis of extracellular matrix (ECM) proteins and matrix metalloproteinases (MMP)-mediated degradation of ECM are generally regarded as hallmarks of early fibrotic tissue response (<xref ref-type="bibr" rid="bib18">Fan et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Krenning et al., 2010</xref>; <xref ref-type="bibr" rid="bib58">Porter and Turner, 2009</xref>; <xref ref-type="bibr" rid="bib67">Shinde and Frangogiannis, 2014</xref>). This essential process maintains tissue integrity, however, it often leads to excessive and adverse CFs remodeling of non-infarcted areas (<xref ref-type="bibr" rid="bib18">Fan et al., 2012</xref>; <xref ref-type="bibr" rid="bib33">Kania et al., 2009</xref>; <xref ref-type="bibr" rid="bib70">Talman and Ruskoaho, 2016</xref>) associated with cardiac dysfunction and increased mortality (<xref ref-type="bibr" rid="bib49">Okada et al., 2005</xref>). Controlled anti-fibrotic strategies still require deeper understanding and advanced models of cardiac fibrosis mechanisms (<xref ref-type="bibr" rid="bib38">Leask, 2010</xref>; <xref ref-type="bibr" rid="bib61">Roubille et al., 2014</xref>).</p><p>In general, the onset of pathological myocardial conditions causes alterations of specific environmental cues at the cellular scale: mechanical strain decreases (loss of contractility); oxygen and nutrient levels dramatically decrease (ischemia); levels of inflammatory cytokines increase (post-injury inflammatory response). In an attempt to provide in vitro models of cardiac disease, CFs have been widely studied under relevant physico-chemical stimulation such as mechanical stress (<xref ref-type="bibr" rid="bib64">Schroer and Merryman, 2015</xref>; <xref ref-type="bibr" rid="bib73">Tomasek et al., 2002</xref>), oxygen deprivation (<xref ref-type="bibr" rid="bib10">Clancy et al., 2007</xref>; <xref ref-type="bibr" rid="bib71">Tamamori et al., 1997</xref>) and biochemical stimulation with pro-fibrotic cytokines (<xref ref-type="bibr" rid="bib16">Edgley et al., 2012</xref>; <xref ref-type="bibr" rid="bib41">Lijnen et al., 2000</xref>; <xref ref-type="bibr" rid="bib54">Petrov et al., 2002</xref>). The application of mechanical stress has been shown to have the following effects on CFs: increased ECM protein synthesis (<xref ref-type="bibr" rid="bib9">Carver et al., 1991</xref>); controversial proliferative behavior (<xref ref-type="bibr" rid="bib3">Atance et al., 2004</xref>; <xref ref-type="bibr" rid="bib7">Butt and Bishop, 1997</xref>; <xref ref-type="bibr" rid="bib12">Dalla Costa et al., 2010</xref>; <xref ref-type="bibr" rid="bib40">Liao et al., 2004</xref>), with recent reports of strain intensity-dependent effects (<xref ref-type="bibr" rid="bib80">Ugolini et al., 2016</xref>); increased production of pro-fibrotic and inflammatory cytokines such as TGF-β (transforming growth factor-beta) (<xref ref-type="bibr" rid="bib37">Leask, 2007</xref>) and TNF-α (tumor necrosis factor-alpha) (<xref ref-type="bibr" rid="bib89">Yokoyama et al., 1999</xref>).</p><p>While previous mechanical stress experiments were performed in a normoxic environment (NX, approximately 20% O<sub>2</sub>, the standard oxygen level of ambient air), CFs were shown to be sensitive to O<sub>2</sub> level variations from physoxia (PX), defined as the physiologic oxygen level in living tissues (about 5–6% O<sub>2</sub> in the myocardium [<xref ref-type="bibr" rid="bib24">Gonschior et al., 1992</xref>; <xref ref-type="bibr" rid="bib62">Roy et al., 2003</xref>; <xref ref-type="bibr" rid="bib65">Sen et al., 2006</xref>; <xref ref-type="bibr" rid="bib86">Winegrad et al., 1999</xref>]). Both hypoxia (HX, 1–3% O<sub>2</sub>) and NX induce a pro-inflammatory and fibrogenic phenotype in cultured CFs (<xref ref-type="bibr" rid="bib62">Roy et al., 2003</xref>; <xref ref-type="bibr" rid="bib66">Sen and Roy, 2010</xref>). These findings imply that normoxic oxygen levels are perceived by CFs as a state of hyperoxia and that a significant bias exists when culturing CFs in non-physiological oxygen environments. The exposure of CFs to HX has been shown to induce collagen production and proliferation of CFs (<xref ref-type="bibr" rid="bib23">Gao et al., 2014</xref>; <xref ref-type="bibr" rid="bib71">Tamamori et al., 1997</xref>), while studies suggest that MMP-based remodeling may not be triggered by HX alone (<xref ref-type="bibr" rid="bib60">Riches et al., 2009</xref>).</p><p>Given the complexity of in vivo pathological evolution, the elucidation of how environmental stimuli interplay and guide cellular responses is paramount. To date, no comprehensive model is able to recapitulate early cellular events taking place after acute myocardial injury and there is no report of cardiac cells subjected to simultaneous mechanical strain and controlled oxygen changes, two major environmental variables involved in cardiac injury and CF adaptive responses. This is mostly due to the lack of compact platforms enabling the controlled application of multiple stimuli.</p><p>To address this need, we here report the improvement of a previously described multi-chamber microdevice dedicated to the application of cyclic strain to cell monolayers (<xref ref-type="bibr" rid="bib80">Ugolini et al., 2016</xref>). By adding a system for controlling oxygen changes, we significantly expanded the experimental complexity and mimicking capabilities of the device. We here finely controlled the applied mechanical strain and oxygen regimes sensed by CFs to model early environmental changes in cardiac injury and provide insights into individual or synergistic contributions of the environmental signals in the activation of early CF responses relevant to cardiac fibrotic disease. Shortly after an ischemic myocardial insult (e.g., acute coronary artery occlusion) tissue oxygen levels drop from approximately 5–6% O<sub>2</sub> (<xref ref-type="bibr" rid="bib24">Gonschior et al., 1992</xref>; <xref ref-type="bibr" rid="bib65">Sen et al., 2006</xref>; <xref ref-type="bibr" rid="bib86">Winegrad et al., 1999</xref>) to near-zero (<xref ref-type="bibr" rid="bib62">Roy et al., 2003</xref>), rapidly inducing loss of cardiac myocytes contractility. In terms of in vitro model parameters, we thus selected 5% O<sub>2</sub> (PX) as a physiological oxygen level and 1% O<sub>2</sub> (HX) as an oxygen level characteristic of ischemic myocardial injury. Dramatic alterations of injured myocardial tissue also take place in early timeframes: tissue bulging and dilations are commonly observed together with loss of contractile function (<xref ref-type="bibr" rid="bib17">Eek et al., 2010</xref>; <xref ref-type="bibr" rid="bib55">Pfeffer and Braunwald, 1990</xref>; <xref ref-type="bibr" rid="bib56">Picard et al., 1990</xref>; <xref ref-type="bibr" rid="bib72">Tennant and Wiggers, 1935</xref>). Cardiac imaging studies agree in the interpretation that global strains are abruptly reduced shortly after myocardial insult (<xref ref-type="bibr" rid="bib19">Flachskampf et al., 2011</xref>; <xref ref-type="bibr" rid="bib30">Hoit, 2011</xref>; <xref ref-type="bibr" rid="bib45">Mollema et al., 2010</xref>). Quantitatively, strain values recorded vary significantly throughout the heart. Although absolute values may depend on imaging algorithms, strains in ischemic/injured regions have been reported to be 2–4 fold lower than in healthy myocardial regions (e.g. less than 3% in ischemic regions versus approximately 10% in healthy regions [<xref ref-type="bibr" rid="bib13">Dandel et al., 2009</xref>; <xref ref-type="bibr" rid="bib84">Vartdal et al., 2007</xref>]). Within this range and in line with previous in vitro observations of CFs behavior (<xref ref-type="bibr" rid="bib80">Ugolini et al., 2016</xref>), we selected 2% strain as indicative of reduced contractility and 8% strain as representative of full myocardial contractility. These environmental changes and the following initial cellular responses happen in a timeframe of hours, as shown in vitro (<xref ref-type="bibr" rid="bib83">van Nieuwenhoven et al., 2013</xref>; <xref ref-type="bibr" rid="bib76">Turner et al., 2007</xref>, <xref ref-type="bibr" rid="bib75">2009</xref>) as well as in vivo (<xref ref-type="bibr" rid="bib26">Guillén et al., 1995</xref>; <xref ref-type="bibr" rid="bib46">Morishita et al., 2015</xref>). We thus performed experiments lasting 24 hr and evaluated the main early aspects that govern fibrotic responses in the injured myocardium: ECM remodeling, with stainings for collagen I and quantifications of MMP expression; proliferation of CFs, with analyses of mitotic cells, Hippo pathway signaling and mitogenic PDGF (platelet-derived growth factor) expression; secretion of inflammatory and pro-fibrotic cytokines in CF supernatants; myofibroblast differentiation, through stainings for αSMA (α-smooth muscle actin). Results of our investigation provide insights into how the combination of environmental stimuli may act synergistically or independently to drive in vitro adaptive early CF responses.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>ECM remodeling</title><p>Myocardial pathological remodeling is largely based on unbalanced CF production of collagen I and MMP-mediated matrix remodeling. To analyze CF-mediated early remodeling events under combined stimulations, we analyzed immunofluorescence images of CFs stained for collagen I. In addition, we quantified the expression of MMP-2 and MMP-3 in cell culture supernatants, two enzymes specifically expressed by CFs during cardiac remodeling (<xref ref-type="bibr" rid="bib18">Fan et al., 2012</xref>). While CFs normally exhibit diffuse cytoplasmic staining for collagen I, an intense staining localized to perinuclear regions of CFs was observed after 24 hr under specific stimulations (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Based on analysis of intracellular fluorescence intensity, we found that the increase in collagen I was similarly triggered by HX alone and 8% strain alone (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). No significant synergy was found for the two stimulations: levels of collagen I are similarly elevated in all HX conditions regardless of strain applied. Correspondingly, collagen I staining exhibits similar intensity in all 8% strain conditions regardless of the oxygen stimulation employed. After only 12 hr of stimulation, collagen I fluorescence showed similar trends, with the exception of HX combined with 8% cyclic strain which provided a greater synergistic effect compared to the single stimulations (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). We also report that culturing CFs at NX levels does not induce significant changes in collagen I presence.<fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.22847.003</object-id><label>Figure 1.</label><caption><title>Analyses of early ECM adaptive responses by CFs subject to combined environmental stimulation.</title><p>(<bold>A</bold>) Representative images of CFs fixed after 24 hr stimulations and stained for collagen I (green) and DAPI (blue). Scale bars = 20 μm. An intense perinuclear staining is observed in CFs stimulated either by 8% mechanical strain or by HX. (<bold>B</bold>) Quantitative fluorescence intensity analyses on Collagen I staining plotted as graph. Collagen I staining is increased by HX, 8% strain or NX conditions. Data collected from one cell donor, two independent experiments, minimum number of experimental replicates n = 4, technical replicates (multiple images per replicate) n = 3. Detected amounts of MMP-2 (<bold>C</bold>) and MMP-3 (<bold>D</bold>) in supernatants of CFs. Both MMP-2 and MMP-3 expression is significantly increased in combined HX and mechanical strain stimulation. Protein secretion data collected from one cell donor, two independent experiments, minimum number of experimental replicates n = 4, technical replicates n = 2. White histograms correspond to 0% strain conditions, grey histograms to 2% strain conditions and black histograms to 8% strain conditions. Two-way ANOVA test was performed for all groups. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. One outlier measurement in MMP-3 expression was detected by performing Grubb’s test (α = 0.05; p&lt;0.05) and removed from the analysis.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.003">http://dx.doi.org/10.7554/eLife.22847.003</ext-link></p><p><supplementary-material id="SD1-data"><object-id pub-id-type="doi">10.7554/eLife.22847.004</object-id><label>Figure 1—source data 1.</label><caption><title>Collagen intensity levels.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.004">http://dx.doi.org/10.7554/eLife.22847.004</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-22847-fig1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22847-fig1-v3"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.22847.005</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Quantitative fluorescence intensity analyses on collagen I staining performed on CFs fixed after 12 hr of combined stimulation.</title><p>Collagen I intensity is increased by HX condition with a more prominent effect when HX was combined to 8% cyclic strain. Data collected from one cell donor, two independent experiments, minimum number of experimental replicates n = 4, technical replicates (multiple images per replicate) n = 3. White histograms correspond to 0% strain conditions, grey histograms to 2% strain conditions and black histograms to 8% strain conditions. Two-way ANOVA test was performed. *p&lt;0.05, ***p&lt;0.001.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.005">http://dx.doi.org/10.7554/eLife.22847.005</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22847-fig1-figsupp1-v3"/></fig></fig-group></p><p>The expression of MMP-2 and MMP-3 in CFs supernatants (<xref ref-type="fig" rid="fig1">Figure 1CD</xref>) was significantly influenced by combined mechanical strain and oxygen changes. MMP-2 was more prominently expressed than MMP-3 (&gt;100X higher). Nevertheless, the expression of both enzymes was similarly regulated by the pattern of stimulations applied: a significant two-fold increase in MMP-2 and MMP-3 expression was induced by the combination of HX and mechanical strain, with a more pronounced increase observed in the HX/2% strain combined conditions. MMP-3 expression was negatively affected when CFs were subjected to mechanical strain at PX or HX stimulus alone.</p></sec><sec id="s2-2"><title>Cell proliferation</title><p>During the proliferative phase of myocardial healing, excessive CF proliferation is observed as well as a phenotypic switch giving rise to the fibrotic response. In order to understand how environmental stimuli modulate the proliferation of human CFs, we examined the fraction of mitotic cells (PHH3<sup>+</sup>/DAPI) under combined mechanical stimulation and changes in oxygen tension. <xref ref-type="fig" rid="fig2">Figure 2A</xref> shows representative images of CFs stained for PHH3 and DAPI. Without application of cyclic strain, we observed a two-fold significant increase in the number of mitotic cells (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) when CFs were stimulated with HX compared to their PX counterparts. Mechanical strain significantly impacted cell proliferation within the PX culture condition: culturing CFs at PX and subjecting them to 2% strain induced a striking increase in mitotic cells compared to no strain control and 8% strain cultures. This strain intensity-dependent effect is in line with our previous investigations of CF proliferation under mechanical strain in NX conditions (<xref ref-type="bibr" rid="bib80">Ugolini et al., 2016</xref>). After 12 hr of stimulation, the proliferative increase with HX is not statistically significant, while we report a significant synergistic decrease of mitotic cells induced by the combination of 8% strain and HX (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>).<fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.22847.006</object-id><label>Figure 2.</label><caption><title>Analyses of CFs proliferation under combined environmental stimulation.</title><p>(<bold>A</bold>) Representative images of CFs fixed after 24 hr stimulations and stained for PHH3 (green) and DAPI (blue). Scale bars = 50 μm. (<bold>B</bold>) Quantitative analyses of mitotic cell fraction plotted as graph. Cell mitosis is increased by either HX alone and by 2% strain at PX. (<bold>C</bold>) Representative images of CFs fixed after 24 hr stimulations and stained for YAP (green) and DAPI (blue). Scale bars = 50 μm. (<bold>D</bold>) Quantitative analyses of cells presenting nuclear YAP plotted as graph. YAP translocation into nuclei is increased by either HX or by 2% strain at PX. Data in Panels B and D were collected from one cell donor, two independent experiments, minimum number of experimental replicates n = 4, technical replicates (multiple images per replicate) n = 3. (<bold>E</bold>) Detected amounts of PDGF in supernatants of CFs plotted as graph. PDGF expression is significantly increased in HX alone and HX combined with mechanical strain stimulation (2% strain). Protein secretion data collected from one cell donor, two independent experiments, minimum number of experimental replicates n = 4, technical replicates n = 2. White histograms correspond to 0% strain conditions, grey histograms to 2% strain conditions and black histograms to 8% strain conditions. Two-way ANOVA test was performed for mitotic cells and nuclear YAP, whereas Kruskal-Wallis test was performed on PDGF expression. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.006">http://dx.doi.org/10.7554/eLife.22847.006</ext-link></p><p><supplementary-material id="SD2-data"><object-id pub-id-type="doi">10.7554/eLife.22847.007</object-id><label>Figure 2—source data 1.</label><caption><title>Mitotic cells and YAP localization data.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.007">http://dx.doi.org/10.7554/eLife.22847.007</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-22847-fig2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22847-fig2-v3"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.22847.008</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Quantification of mitotic cells (PHH3<sup>+</sup>/DAPI) performed on CFs fixed after 12 hr of combined stimulation (PX, HX and mechanical strain).</title><p>Cell mitosis is negatively regulated by 8% cyclic strain combined with HX condition. Data collected from one cell donor, two independent experiments, minimum number of experimental replicates n = 4, technical replicates (multiple images per replicate) n = 3. White histograms correspond to 0% strain conditions, grey histograms to 2% strain conditions and black histograms to 8% strain conditions. Two-way ANOVA test was performed. *p&lt;0.05.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.008">http://dx.doi.org/10.7554/eLife.22847.008</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22847-fig2-figsupp1-v3"/></fig></fig-group></p><p>In addition, we performed mitotic cell counts on CFs cultured under NX conditions without mechanical strain in order to evaluate any influence of non-physiological oxygen environments on CF proliferation. Interestingly, CFs exhibited much greater mitosis under NX environments (approx. 5% mitotic cells) compared to PX environments (approx. 1% mitotic cells) denoting a strong proliferative effect of standard cell culture environments.</p><p>Further, we evaluated the effects of the environmental changes on YAP, a transcription factor mainly known as the principal effector of the Hippo proliferative pathway, a crucial pathway involved in cardiac regeneration and repair (<xref ref-type="bibr" rid="bib51">Papizan and Olson, 2014</xref>; <xref ref-type="bibr" rid="bib88">Xin et al., 2013</xref>). Recent literature has also described a parallel mechano-sensing associated role of YAP (<xref ref-type="bibr" rid="bib15">Dupont et al., 2011</xref>; <xref ref-type="bibr" rid="bib47">Mosqueira et al., 2014</xref>). YAP translocation from cytoplasm to nucleus leads to inactivation of Hippo pathway and a subsequent increase in cell proliferation. We therefore quantified nuclear localization of YAP by means of immunofluorescence, which revealed that the fraction of CFs displaying nuclear YAP is influenced by the combination of stimuli with trends similar to the fraction of mitotic cells (<xref ref-type="fig" rid="fig2">Figure 2C,D</xref>). In CFs cultured at PX, 2% strain induces higher YAP translocation into cell nuclei. CFs solely exposed to HX environment show a significant two-fold increase in nuclear YAP compared to a PX environment. Mechanical strain shows a negative interaction when combined with HX, with CFs subject to HX/8% strain condition showing lower fractions of nuclear YAP compared to CFs subject to HX alone. This effect can also be observed in the analysis of mitotic cells, although the result is not statistically significant. Interestingly, CFs cultured in an NX environment show a three-fold increase in nuclear YAP compared to PX conditions.</p><p>Finally, we detected the expression of PDGF in CF supernatants. PDGF has been described as a potent mitogen for CFs, is significantly over-expressed in in vivo models of heart injury (<xref ref-type="bibr" rid="bib91">Zhao et al., 2011</xref>), and has recently been studied as a putative pharmacological target for attenuating adverse effects of cardiac fibrotic disease (<xref ref-type="bibr" rid="bib43">Liu et al., 2014</xref>). Expression of PDGF in CF culture supernatant (<xref ref-type="fig" rid="fig2">Figure 2E</xref>) was significantly affected by HX stimulation: a four-fold increase in the detected amounts of PDGF was observed in HX compared to PX, without application of cyclic strain. Mechanical stimulation showed a negative interaction with the HX-induced secretion of PDGF: while levels of PDGF expression remain elevated under HX/2% strain, application of 8% cyclic strain shows a negative regulation of PDGF secretion back to PX levels of expression.</p></sec><sec id="s2-3"><title>Cytokine secretion</title><p>Acute inflammatory tissue responses after myocardial injuries are thought to be largely based on cellular signaling by means of secreted factors. The precise contribution of CFs in the regulation of the early inflammatory response in myocardial remodeling is still to be determined, however, recent reports suggest that CFs play a key role in modulating a functional inflammasome that includes inflammatory and pro-fibrotic cytokines (<xref ref-type="bibr" rid="bib34">Kawaguchi et al., 2011</xref>; <xref ref-type="bibr" rid="bib42">Lindner et al., 2014</xref>; <xref ref-type="bibr" rid="bib78">Turner, 2016</xref>). We therefore studied the amount of inflammatory cytokines (namely interleukins IL-1β, IL-6 and TNF-α) and of pro-fibrotic TGF-β in CF culture supernatants after 24 hr of combined stimulations (<xref ref-type="fig" rid="fig3">Figure 3</xref>).<fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.22847.009</object-id><label>Figure 3.</label><caption><title>Analyses of pro-fibrotic and pro-inflammatory cytokines in supernatants of CFs.</title><p>(<bold>A</bold>) TGF-β expression in supernatants. TGF-β expression resulted significantly increased by the combination of HX and mechanical strain (2% strain). (<bold>B</bold>) Expression of IL-1β in CFs supernatants. IL-1β expression resulted significantly upregulated by the combination of HX and mechanical strain (2% strain). (<bold>C</bold>) TNF-α expression in supernatants. Extremely low amounts were detected and environmental stimulations do not induce significant differences in the expression. (<bold>D</bold>) IL-6 expression in supernatants. IL-6 resulted abundantly expressed by CFs with no statistically significant differences induced by environmental stimulations. Protein secretion data from each marker was collected from one cell donor, two independent experiments, minimum number of experimental replicates n = 4, technical replicates n = 2. White histograms correspond to 0% strain conditions, grey histograms to 2% strain conditions and black histograms to 8% strain conditions. Kruskal-Wallis tests were performed for all groups except for IL-6 analyzed with Two-way ANOVA tests. *p&lt;0.05, **p&lt;0.01, ns = non-significant.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.009">http://dx.doi.org/10.7554/eLife.22847.009</ext-link></p><p><supplementary-material id="SD3-data"><object-id pub-id-type="doi">10.7554/eLife.22847.010</object-id><label>Figure 3—source data 1.</label><caption><title>Protein expression data.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.010">http://dx.doi.org/10.7554/eLife.22847.010</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-22847-fig3-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22847-fig3-v3"/></fig></p><p>TGF-β is a major contributor to fibrotic responses, widely studied across a variety of tissues and organs. During post-injury myocardial remodeling, TGF-β is known to stimulate a wide range of CF responses from phenotypic switch to collagen synthesis and ECM remodeling (<xref ref-type="bibr" rid="bib37">Leask, 2007</xref>). CFs stimulated with a combination of HX and mechanical strain (specifically 2% strain) were found to increase secretion of TGF-β by approximately two-fold. CFs cultured at PX expressed lower amounts of TGF-β, regardless of the mechanical strain applied (<xref ref-type="fig" rid="fig3">Figure 3A</xref>).</p><p>IL1-β is one of the first cytokines detected in vivo after myocardial injury (<xref ref-type="bibr" rid="bib26">Guillén et al., 1995</xref>) and is known to stimulate CF response including the production of MMPs (<xref ref-type="bibr" rid="bib6">Brown et al., 2007</xref>; <xref ref-type="bibr" rid="bib27">Guo et al., 2008</xref>; <xref ref-type="bibr" rid="bib68">Siwik et al., 2000</xref>). Interestingly, we found that a significant two-fold increase in IL1-β expression occurred only when CFs were subjected to the combination of HX and mechanical strain, particularly with 2% strain (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p><p>Conversely, we observed how the expression of inflammatory cytokines TNF-α and IL-6 was not influenced by the application of environmental stimuli. We detected extremely low amounts of TNF-α (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), with non-significant variations across all stimulation conditions. IL-6 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>) was abundantly expressed by CFs yet none of the differences in its expression were found to be statistically significant.</p></sec><sec id="s2-4"><title>Myofibroblast differentiation</title><p>In the remodeling myocardium, CFs undergo a phenotypic modulation to myofibroblasts, a motile and contractile cell type that maintains tissue integrity and promotes scar formation and tissue fibrosis (<xref ref-type="bibr" rid="bib63">Santiago et al., 2010</xref>). The hallmark of this phenotype switch is the expression of alpha-smooth muscle actin (αSMA) that, by being incorporated into actin stress fibers, confers increased mechanical and motile capabilities to differentiated myofibroblasts (<xref ref-type="bibr" rid="bib4">Baum and Duffy, 2011</xref>). To analyze whether CFs differentiation into myofibroblasts took place under environmental changes we evaluated expression and localization of αSMA after 24 hr of combined stimulation. Immunostainings of CFs (<xref ref-type="fig" rid="fig4">Figure 4</xref>) reveal that a basal expression of cytoplasmic αSMA is present in all combined stimulation conditions. However, under no experimental condition did CFs exhibit co-localization of αSMA (red) and actin stress fibers (green), indicating that differentiation into myofibroblasts was not induced by our pattern of environmental stimuli. Conversely, stimulating CFs by supplementing TGF-β in the culture medium (a known inducer of CF differentiation to myofibroblasts) caused the appearance of cells exhibiting superimposed αSMA and actin signal (yellow).<fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.22847.011</object-id><label>Figure 4.</label><caption><title>Representative images of CFs fixed after 24 hr combined stimulations (<bold>A–F</bold>) and stained for actin (green) and αSMA (red), nuclei were counterstained with DAPI (blue).</title><p>Scale bars = 20 μm. αSMA is similarly expressed in all conditions and diffused in perinuclear and cytoplasmic localization. (<bold>G</bold>) Positive control for αSMA immunofluorescence through stimulation with 30 ng/ml TGF-β: CFs exhibit co-localization of αSMA staining with actin stress fibers (resulting in yellow signal) denoting differentiation into myofibroblasts (white arrows). Representative images were collected from a pool of images obtained from one cell donor, one independent experiment, minimum number of experimental replicates n = 4, technical replicates n = 3.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.011">http://dx.doi.org/10.7554/eLife.22847.011</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22847-fig4-v3"/></fig></p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Microenvironmental changes taking place in the injured myocardium trigger tissue responses that are orchestrated between multiple cell types (mainly cardiac myocytes, cardiac fibroblasts and immune cells) and involve multiple cell functions and signaling pathways. The outcome of this process is a substantial remodeling of the injured myocardial region by ECM-producing CFs that often results in excessive and dysfunctional alterations of the myocardial architecture and functionality. The elucidation of pathological cellular routes leading to tissue-level failure can clearly benefit from effective in vitro studies capable of dissecting and analyzing responses to multiple physiological and pathological conditions. Microfluidic technologies have recently enabled the development of advanced cardiac models by integrating key environmental cues in cardiac cell cultures (<xref ref-type="bibr" rid="bib1">Agarwal et al., 2013</xref>; <xref ref-type="bibr" rid="bib44">Marsano et al., 2016</xref>; <xref ref-type="bibr" rid="bib52">Pavesi et al., 2015</xref>; <xref ref-type="bibr" rid="bib81">Uzel et al., 2014</xref>). We here investigated CF behaviors in a compact multi-chamber in vitro platform designed to perform cell cultures under combined mechanical stimulation and changes in oxygen levels. This novel tool enabled us to perform for the first time a systematic evaluation of early CF responses to the combination of oxygen levels and mechanical strain regimes that facilitate a more realistic model of cardiac physiology and pathology.</p><p>Despite being overlooked in most previous studies, rigorous replication of in vivo oxygen tensions proved fundamental for interpreting physiological and pathological CF responses (<xref ref-type="bibr" rid="bib62">Roy et al., 2003</xref>). Two oxygen conditions were tested: physiological oxygen levels experienced by CFs in the myocardium (5% O<sub>2</sub>, PX) and a rapid decrease of oxygen levels resembling an acute ischemic event (1% O<sub>2</sub>, HX). We also performed analyses on CFs cultured under non-physiological normoxic (NX) conditions and confirmed a substantial impact of NX compared to PX, especially on cell proliferation.</p><p>The mechanical microenvironment is known to change upon cardiac injury. It is known that injured myocardial regions are characterized by an early reduction of mechanical load due to loss of contractile cardiac myocytes (<xref ref-type="bibr" rid="bib17">Eek et al., 2010</xref>; <xref ref-type="bibr" rid="bib55">Pfeffer and Braunwald, 1990</xref>; <xref ref-type="bibr" rid="bib56">Picard et al., 1990</xref>; <xref ref-type="bibr" rid="bib72">Tennant and Wiggers, 1935</xref>). We therefore focused on evaluating how significant changes in mechanical strain affect cellular responses. To explore these effects we employed low cyclic strain mimicking reduced contractility (2% strain), physiological cyclic strain (8% strain) and a static control. These values were based on cardiac imaging studies performed shortly after myocardial injury (<xref ref-type="bibr" rid="bib13">Dandel et al., 2009</xref>; <xref ref-type="bibr" rid="bib84">Vartdal et al., 2007</xref>) and were previously reported to elicit strain-dependent effects in CFs (<xref ref-type="bibr" rid="bib80">Ugolini et al., 2016</xref>).</p><p>Pathological remodeling of the myocardium involves activation of multiple CF cell functions. In a significant step forward compared to previous studies, our analyses encompassed most known pathological responses of CFs: production of ECM proteins and ECM-remodeling enzymes, cellular proliferation, secreted pro-fibrotic or inflammatory cytokines and myofibroblast differentiation. This in-depth assessment demonstrates how environmental factors participate in driving CF pathological responses and elucidates the existence of separate and synergistic roles of mechanical stimulation and oxygen levels in directing cellular functions relevant to early phases of cardiac fibrotic remodeling.</p><p>Our findings demonstrated that upon sensing of hypoxic environments CFs quickly (&lt;24 hr) activate proliferative responses (<xref ref-type="table" rid="tbl1">Table 1</xref>). We propose that the increase in cell proliferation is mediated by the Hippo pathway given the correlation between nuclear YAP translocation and mitotic cells (PHH3<sup>+</sup>). YAP is widely recognized as a key factor in cardiac repair (<xref ref-type="bibr" rid="bib51">Papizan and Olson, 2014</xref>; <xref ref-type="bibr" rid="bib88">Xin et al., 2013</xref>). We found, however, that in contrast with other studies performed at NX (<xref ref-type="bibr" rid="bib11">Codelia et al., 2014</xref>), YAP nuclear translocation is not related to increasing cyclic mechanical strain. In addition, an increased secretion of mitogenic PDGF by CFs at HX suggests a possible autocrine CF mechanism aimed at modulating proliferation upon pathological myocardial conditions.<table-wrap id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.22847.012</object-id><label>Table 1.</label><caption><p>Summary of the main cellular responses observed in experiments of combined environmental stimulation. Cellular responses were included in the corresponding stimulation condition if the measured parameter was significantly different from the parameter at reference condition PX(5% O<sub>2</sub>)/0% strain (single arrow ↑) and if more than two-fold significant difference was observed compared to PX(5% O<sub>2</sub>)/0% strain condition (double arrow ↑↑). Different background cell color are added as a function of the number of significant cellular responses observed (yellow: 2 or less changes; orange: up to 5 changes; red: more than 5 changes).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.012">http://dx.doi.org/10.7554/eLife.22847.012</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th><bold>0% Strain</bold></th><th><bold>2% Strain</bold></th><th><bold>8% Strain    </bold></th></tr></thead><tbody><tr><td align="left"><bold>HX</bold> <break/><bold>(1% O</bold><sub><bold>2</bold></sub>)</td><td align="left" style="author-callout-style-b3">↑↑ <italic>Mitosis</italic> <break/>↑↑ <italic>Nuclear YAP</italic> <break/>↑↑ <italic>PDGF</italic> <break/>↑ <italic>Collagen</italic> <break/>↓ <italic>MMP-3</italic></td><td align="left" style="author-callout-style-b6">↑ <italic>Mitosis</italic> <break/>↑ <italic>Nuclear YAP</italic> <break/>↑↑ <italic>PDGF</italic> <break/>↑ <italic>Collagen</italic> <break/>↑↑ <italic>MMP-2–3</italic> <break/>↑↑<italic>TGF-β</italic> <break/>↑ <italic>IL-1β</italic></td><td align="left" style="author-callout-style-b4">↑ <italic>Collagen</italic> <break/>↑ <italic>MMP-2</italic></td></tr><tr><td><bold>PX</bold> <break/><bold>(5% O</bold><sub><bold>2</bold></sub>)</td><td><italic>Reference</italic> <break/><italic>condition</italic></td><td style="author-callout-style-b3">↑ <italic>Mitosis</italic> <break/>↑↑ <italic>Nuclear YAP</italic> <break/>↓ <italic>MMP-3</italic></td><td style="author-callout-style-b4">↑ <italic>Collagen</italic> <break/>↓ <italic>MMP-3</italic></td></tr></tbody></table></table-wrap></p><p>We also showed that hypoxia alone causes an increased collagen presence in CFs cultures. This is consistent with data obtained in previous works focused on collagen production by CFs subject to HX (<xref ref-type="bibr" rid="bib71">Tamamori et al., 1997</xref>). We therefore demonstrated how HX alone induces pro-fibrotic responses in CFs.</p><p>A significant novel insight observed in the present study is that the combination of HX and mechanical strain incrementally instructed further pathological cell responses. Indeed, the production of pro-fibrotic TGF-β, inflammatory cytokine IL1-β and matrix-degrading enzymes (MMP-2 and MMP-3) significantly increased only when cells were subject to combined HX and low levels of cyclic strain (HX/2% strain). TGF-β is markedly upregulated in vivo in regions of cardiac tissue injury and is known to act in vitro on CFs phenotypic switch, proliferation and collagen synthesis (<xref ref-type="bibr" rid="bib37">Leask, 2007</xref>; <xref ref-type="bibr" rid="bib41">Lijnen et al., 2000</xref>). IL1-β has been described in vivo as an early (&lt;10 hr) post-injury inflammatory cytokine (<xref ref-type="bibr" rid="bib26">Guillén et al., 1995</xref>) and CFs are thought to be one of the main cellular sources of IL1-β (<xref ref-type="bibr" rid="bib77">Turner, 2014</xref>). MMPs are known to be primarily involved in the remodeling of the injured myocardium and it is worth noting that previous studies reported inhibitory effects of HX alone on MMP expression (<xref ref-type="bibr" rid="bib60">Riches et al., 2009</xref>). In another study, mechanical stress did not alter MMP expression unless cells were cultured in serum deprivation (<xref ref-type="bibr" rid="bib79">Tyagi et al., 1998</xref>). This context strengthens the hypothesis of a combined contribution of environmental conditions in driving MMP secretion by CFs, and the importance of reproducing complex environmental changes in vitro. In addition, literature suggests a direct effect of TGF-β and IL1-β on the expression of MMPs in CFs (<xref ref-type="bibr" rid="bib6">Brown et al., 2007</xref>; <xref ref-type="bibr" rid="bib69">Stawowy et al., 2004</xref>) and we observed how the expression levels of TGF-β and IL1-β under combined stimulation are in line with the altered expression of MMPs. Further studies may therefore be directed towards the elucidation of such possible autocrine mechanisms regulating CFs-mediated ECM remodeling. Notably, no experimental condition led to myofibroblast differentiation, with the exception of the positive control (additional biochemical stimulation with TGF-β), thus highlighting the importance of soluble pro-fibrotic factors for this aspect of CF pathological activation.</p><p>Intriguingly, we found that when cells were subject to physiological cyclic strain (8% strain) together with HX condition, most of the above pathological CF responses were not observed and we found only a modest increase in collagen presence. Similarly, when oxygen conditions resemble those of healthy tissue (PX), cyclic mechanical strain only results in increased collagen presence (at 8% strain) or in increased proliferation (at 2% strain). These results are in line with previous studies (performed in NX environments) on mechanically stimulated CFs (<xref ref-type="bibr" rid="bib9">Carver et al., 1991</xref>; <xref ref-type="bibr" rid="bib32">Husse et al., 2007</xref>; <xref ref-type="bibr" rid="bib80">Ugolini et al., 2016</xref>).</p><p>Overall, these outcomes suggest that CFs respond differently to different regimes of cyclic strain, to different oxygen conditions and to combinations of these. In the context of an acute myocardial insult, loss of contractility and decrease in sensed oxygen levels are able to instruct a consistent response of CFs that involves matrix remodeling, inflammatory and proliferative behaviors. Our combined conditions allowed us to report that a mechanical environment resembling full contractility (8% strain) may hold a protective potential and resulted in attenuating CFs inflammatory, remodeling and pro-fibrotic responses taking place in HX.</p><p>These findings help to validate an on-chip model capable of exploring in vitro early fibrotic responses elicited in the injured myocardium. To estimate how this novel approach quantitatively correlates with standard readouts associated with cardiac fibrotic responses, we compared the fold changes of CF markers assessed in our model to those observed in standard in vitro models. Standard approaches typically involve the biochemical stimulation of CFs with known concentrations of pro-fibrotic (e.g., TGF-β) or inflammatory (e.g., interleukins) molecules. We collected literature studies where protein expression of relevant markers was measured at early stages of CFs culture under pro-fibrotic/inflammatory conditions. <xref ref-type="table" rid="tbl2">Table 2</xref> shows quantitative comparisons between standard models and our on-chip model. Our model correlates well with quantitative readouts involving ECM, ECM-remodeling enzymes (collagen and MMPs expression) and proliferative effects, although contradictory studies also showed decreased CF proliferation under pro-fibrotic stimuli. Notably, MMP levels in serum were shown to increase by approximately two-fold in patients after 24 hr from acute myocardial injury diagnosis (<xref ref-type="bibr" rid="bib46">Morishita et al., 2015</xref>). As for CF secretion of pro-fibrotic and inflammatory factors, our model was able to capture the triggering of PDGF expression by CFs, an aspect not yet described by standard in vitro approaches. Interestingly, this also correlated with in vivo increments in plasma levels of PDGF (approximately two-fold increment) at the early onset (12 hr) of myocardial injury in human patients (<xref ref-type="bibr" rid="bib35">Koizumi et al., 2015</xref>). Additionally, our results correlated with secretion of TGF-β and IL-1β, while our environment-based model did not induce significant changes to the secreted levels of IL-6 and TNF-α as in standard models.<table-wrap id="tbl2" position="float"><object-id pub-id-type="doi">10.7554/eLife.22847.013</object-id><label>Table 2.</label><caption><p>Summary of literature studies investigating early CFs responses under standard pro-fibrotic and inflammatory stimulation. Quantitative fold-changes of selected markers (fibrotic vs. control condition) are reported for studies that carried out protein expression assays or proliferation assays at early stimulation timepoints and compared to our on-chip model (grey background). The on-chip model well correlates to standard in vitro models in terms of ECM remodeling markers (Collagen 1, MMPs), cell proliferation and pro-fibrotic or inflammatory cytokynes (TGF-β and IL-1β). The on-chip model did not elicit production of IL-6 and TNF-α as compared to standard in vitro models. Assays: WB=Western Blot; ELISA= Enzyme-linked immunosorbent assay; HP= Hydroxyproline assay; CCK-8= Cell-counting kit eight proliferation assay; FACS= Fluorescence-activated cell sorting; Count= Standard cell counting; BrdU= Bromodeoxyuridine proliferation assay. Chemical stimuli: Ang II= Angiotensin II; TGF-β= Transforming Growth Factor-β; IL-1α/IL-1β= Interleukin-1α/1β; TNF-α= Tumor Necrosis Factor-α. Source data file linked to <xref ref-type="table" rid="tbl2">Table 2</xref> shows this comparison data plotted in a chart.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.013">http://dx.doi.org/10.7554/eLife.22847.013</ext-link></p><p><supplementary-material id="SD4-data"><object-id pub-id-type="doi">10.7554/eLife.22847.014</object-id><label>Table 2—source data 1.</label><caption><title>Data from <xref ref-type="table" rid="tbl2">Table 2</xref> plotted as chart.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.014">http://dx.doi.org/10.7554/eLife.22847.014</ext-link></p></caption><media mime-subtype="jpeg" mimetype="image" xlink:href="elife-22847-table2-data1-v3.jpg"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="center" colspan="7" valign="top"><break/><bold>Collagen Expression</bold></td></tr><tr><td>Ref.</td><td>Species</td><td>Assay</td><td>Stimulus</td><td>Culture Time</td><td>Change vs. control <break/>(standard model)</td><td>Change vs. control <break/>(24 hr on-chip model)</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib87">Xiao et al., 2016</xref>)</td><td valign="top">Mouse</td><td valign="top">WB</td><td valign="top">Ang II</td><td valign="top">24 hr</td><td valign="top">↑1.5-fold</td><td rowspan="5" style="author-callout-style-b8">↑1.45-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib28">Guo et al., 2016</xref>)</td><td valign="top">Rat</td><td valign="top">WB</td><td valign="top">TGF-β</td><td valign="top">48 hr</td><td valign="top">↑2.2-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib50">Pan et al., 2013</xref>)</td><td valign="top">Rat</td><td valign="top">WB</td><td valign="top">TGF-β</td><td valign="top">24 hr</td><td valign="top">↑1.5-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib53">Peng et al., 2010</xref>)</td><td valign="top">Human</td><td valign="top">HP</td><td valign="top">TGF-β</td><td valign="top">48 hr</td><td valign="top">↑1.6-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib39">Li et al., 2015</xref>)</td><td valign="top">Rat</td><td valign="top">WB</td><td valign="top">Ang II</td><td valign="top">24 hr</td><td valign="top">↑2.1-fold</td></tr><tr><td align="center" colspan="7" valign="top"><break/><bold>MMP-2 Expression</bold></td></tr><tr><td>Ref.</td><td>Species</td><td>Assay</td><td>Stimulus</td><td>Culture Time</td><td>Change vs. control <break/>(standard model)</td><td>Change vs. control <break/>(24 hr on-chip model)</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib87">Xiao et al., 2016</xref>)</td><td valign="top">Mouse</td><td valign="top">WB</td><td valign="top">Ang II</td><td valign="top">24 hr</td><td valign="top">↑1.8-fold</td><td rowspan="4" style="author-callout-style-b8">↑2-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib59">Rhaleb et al., 2013</xref>)</td><td valign="top">Rat</td><td valign="top">WB</td><td valign="top">IL-1β</td><td valign="top">72 hr</td><td valign="top">↑2-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib6">Brown et al., 2007</xref>)</td><td valign="top">Rat</td><td valign="top">WB</td><td valign="top">IL-1</td><td valign="top">48 hr</td><td valign="top">↑2.2-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib39">Li et al., 2015</xref>)</td><td valign="top">Rat</td><td valign="top">WB</td><td valign="top">Ang II</td><td valign="top">24 hr</td><td valign="top">↑2-fold</td></tr><tr><td align="center" colspan="7" valign="top"><bold>MMP-3 Expression</bold></td></tr><tr><td>Ref.</td><td>Species</td><td>Assay</td><td>Stimulus</td><td>Culture Time</td><td>Change vs. control <break/>(standard model)</td><td>Change vs. control <break/>(24 hr on-chip model)</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib83">van Nieuwenhoven et al., 2013</xref> )</td><td valign="top">Human</td><td valign="top">WB</td><td valign="top">IL-1α</td><td valign="top">24 hr</td><td valign="top">↑2-fold</td><td rowspan="2" style="author-callout-style-b8">↑2.7-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib6">Brown et al., 2007</xref>)</td><td valign="top">Rat</td><td valign="top">WB</td><td valign="top">IL-1</td><td valign="top">48 hr</td><td valign="top">↑2-fold</td></tr><tr><td align="center" colspan="7" valign="top"><bold>Cell proliferation</bold></td></tr><tr><td>Ref.</td><td>Species</td><td>Assay</td><td>Stimulus</td><td>Culture Time</td><td>Change vs. control <break/>(standard model)</td><td>Change vs. control <break/>(24 hr on-chip model)</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib87">Xiao et al., 2016</xref>)</td><td valign="top">Mouse</td><td valign="top">CCK-8</td><td valign="top">Ang II</td><td valign="top">24 hr</td><td valign="top">↑2-fold</td><td rowspan="7" style="author-callout-style-b8">↑1.9-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib28">Guo et al., 2016</xref>)</td><td valign="top">Rat</td><td valign="top">FACS</td><td valign="top">TGF-β</td><td valign="top">48 hr</td><td valign="top">↑2-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib57">Porter et al., 2004</xref>)</td><td valign="top">Human</td><td valign="top">Count</td><td valign="top">TNF-α</td><td valign="top">4 days</td><td valign="top">↑1.5-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib14">Dobaczewski et al., 2010</xref>)</td><td valign="top">Mouse</td><td valign="top">BrdU</td><td valign="top">TGF-β</td><td valign="top">24 hr</td><td valign="top"><bold>↓</bold>2-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib85">Vivar et al., 2016</xref>)</td><td valign="top">Rat</td><td valign="top">FACS</td><td valign="top">TGF-β</td><td valign="top">72 hr</td><td valign="top"><bold>↓</bold>2-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib2">Ai et al., 2015</xref>)</td><td valign="top">Rat</td><td valign="top">CCK-8</td><td valign="top">Ang II</td><td valign="top">48 hr</td><td valign="top">↑1.8-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib39">Li et al., 2015</xref>)</td><td valign="top">Rat</td><td valign="top">MTT</td><td valign="top">Ang II</td><td valign="top">24 hr</td><td valign="top">↑2-fold</td></tr><tr><td align="center" colspan="7" valign="top"><bold>TGF- β Expression</bold></td></tr><tr><td>Ref.</td><td>Species</td><td>Assay</td><td>Stimulus</td><td>Culture Time</td><td>Change vs. control <break/>(standard model)</td><td>Change vs. control <break/>(24 hr on-chip model)</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib25">Gu et al., 2012</xref>)</td><td valign="top">Mouse</td><td valign="top">WB</td><td valign="top">Ang II</td><td valign="top">24 hr</td><td valign="top">↑2-fold</td><td rowspan="4" style="author-callout-style-b8">↑2.7-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib87">Xiao et al., 2016</xref>)</td><td valign="top">Mouse</td><td valign="top">WB</td><td valign="top">Ang II</td><td valign="top">24 hr</td><td valign="top">↑1.8-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib2">Ai et al., 2015</xref>)</td><td valign="top">Rat</td><td valign="top">ELISA</td><td valign="top">Ang II</td><td valign="top">48 hr</td><td valign="top">↑2.5-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib39">Li et al., 2015</xref>)</td><td valign="top">Rat</td><td valign="top">WB</td><td valign="top">Ang II</td><td valign="top">24 hr</td><td valign="top">↑1.9-fold</td></tr><tr><td align="center" colspan="7" valign="top"><bold>IL-1β Expression</bold></td></tr><tr><td>Ref.</td><td>Species</td><td>Assay</td><td>Stimulus</td><td>Culture Time</td><td>Change vs. control <break/>(standard model)</td><td>Change vs. control <break/>(24 hr on-chip model)</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib75">Turner et al., 2009</xref>)</td><td valign="top">Human</td><td valign="top">ELISA</td><td valign="top">IL-1α</td><td valign="top">24 hr</td><td valign="top">↑8-fold</td><td rowspan="2" style="author-callout-style-b8">↑2.2-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib75">Turner et al., 2009</xref>)</td><td valign="top">Human</td><td valign="top">ELISA</td><td valign="top">TNF-α</td><td valign="top">24 hr</td><td valign="top">↑2-fold</td></tr><tr><td align="center" colspan="7" valign="top"><bold>TNF-α Expression</bold></td></tr><tr><td>Ref.</td><td>Species</td><td>Assay</td><td>Stimulus</td><td>Culture Time</td><td>Change vs. control <break/>(standard model)</td><td>Change vs. control <break/>(24 hr on-chip model)</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib75">Turner et al., 2009</xref>)</td><td valign="top">Human</td><td valign="top">ELISA</td><td valign="top">IL-1α</td><td valign="top">24 hr</td><td valign="top">↑4-fold</td><td rowspan="3" style="author-callout-style-b8">ns</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib31">Humeres et al., 2016</xref>)</td><td valign="top">Rat</td><td valign="top">Luminex</td><td valign="top">TGF-β</td><td valign="top">72 hr</td><td valign="top"><bold>↓</bold>4-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib89">Yokoyama et al., 1999</xref>)</td><td valign="top">Rat</td><td valign="top">ELISA</td><td valign="top">Ang II</td><td valign="top">6h</td><td valign="top">↑5-fold</td></tr><tr><td align="center" colspan="7" valign="top"><bold>IL-6 Expression</bold></td></tr><tr><td>Ref.</td><td>Species</td><td>Assay</td><td>Stimulus</td><td>Culture Time</td><td>Change vs. control <break/>(standard model)</td><td>Change vs. control <break/>(24 hr on-chip model)</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib75">Turner et al., 2009</xref>)</td><td valign="top">Human</td><td valign="top">ELISA</td><td valign="top">IL-1α</td><td valign="top">24 hr</td><td valign="top">↑19-fold</td><td rowspan="3" style="author-callout-style-b8">ns</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib75">Turner et al., 2009</xref>)</td><td valign="top">Human</td><td valign="top">ELISA</td><td valign="top">TNF-α</td><td valign="top">24 hr</td><td valign="top">↑3.5-fold</td></tr><tr><td valign="top">(<xref ref-type="bibr" rid="bib76">Turner et al., 2007</xref>)</td><td valign="top">Human</td><td valign="top">ELISA</td><td valign="top">TNF-α</td><td valign="top">24 hr</td><td valign="top">↑2.8-fold</td></tr></tbody></table></table-wrap></p><p>This last missing readout suggests that indirect paracrine action provided by other cellular actors involved in myocardial homeostasis and typically modeled in standard biochemical stimulation approaches is likely to play a role in driving the inflammatory responses that are not captured in our model. For instance, immune cells such as monocytes or macrophages are known to infiltrate the injured myocardium, supporting the inflammatory environment and providing additional paracrine cytokines to CFs (<xref ref-type="bibr" rid="bib82">van Amerongen et al., 2007</xref>; <xref ref-type="bibr" rid="bib21">Frantz et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Nahrendorf et al., 2010</xref>). In addition, cross talk between cardiac myocytes and CFs has been widely described (<xref ref-type="bibr" rid="bib8">Cartledge et al., 2015</xref>; <xref ref-type="bibr" rid="bib90">Zhang et al., 2012</xref>) and shown to drive CF behaviors such as myofibroblast differentiation(<xref ref-type="bibr" rid="bib74">Tsoporis et al., 2012</xref>) and increased production of inflammatory molecules (<xref ref-type="bibr" rid="bib5">Bowers et al., 2010</xref>). These indirect mechanisms could help evoke additional responses not captured in our model or could increase to an even greater magnitude the ones that we described as driven by environmental signals. Direct effects of cardiomyocyte contractility also mechanically influence CF behavior in vivo, however, this aspect is recreated in vitro by our system that exposes cultured CFs to uniform but tunable mechanical signals, thus proving advantageous for improving the clarity of readouts. Further improvements to the current model, such as the addition of paracrine signaling with other cell types, represents a promising future direction for this work, with the aim of developing a more accurate on-chip model combining fine control over the microenvironment with realistic biochemical signaling.</p><sec id="s3-1"><title>Conclusions</title><p>In summary, we propose an innovative model that recreates a pathological environment for understanding CF responses during cardiac injury. Replicating for the first time the combination of oxygen changes and mechanical cues, we revealed how these environmental stimulations combine to trigger CF pathological responses and highlighted emerging adaptive cellular mechanisms. We found that mimicking the combination of HX and reduced contractility proved crucial in eliciting inflammatory and fibrotic remodeling responses of CFs, while individual environmental stimuli only regulated proliferative and collagen-related responses. These insights have impact on future studies of pathological myocardial remodeling and the in vitro model here described provides a tool for better understanding pathological mechanisms and tailoring reparative strategies.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Experimental design</title><p><xref ref-type="fig" rid="fig5">Figure 5</xref> shows a detailed representation of oxygen dynamics and mechanical strain conditions employed (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>) together with a timeline of experiments (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). After cells seeding, CFs were kept in static incubation for 12 hr in order to allow for cell adhesion. Subsequently – being this initial time-point referred to as t0 – CFs seeded in the inlet and outlet wells of the culture chambers were manually scraped, aspirated and stimulations were started. We employed two mechanical stimulation regimes (<xref ref-type="fig" rid="fig5">Figure 5B</xref>): 2% strain or 8% strain at 1 Hz. Concerning the oxygenation stimulus applied, the microdevices were employed at a base environmental oxygen level corresponding to physoxia (5% O<sub>2</sub>) in order to precisely model the oxygen levels in healthy myocardium until t0. Then, two oxygen concentration dynamics were imposed (<xref ref-type="fig" rid="fig5">Figure 5C</xref>): (i) a static incubation at 5% O<sub>2</sub> (physoxia, PX) for 24 hr, (ii) an abrupt reduction of oxygen concentrations to 1% O<sub>2</sub> that was maintained for 24 hr (hypoxia, HX). CFs were subject to all possible combinations of the above stimuli (six total conditions) for a total of 24 hr. Immunofluorescence analyses were performed after 12 hr and 24 hr of stimulation, while cell culture supernatants were collected and analyzed after 24 hr of stimulation. Immunofluorescence analyses were also performed on CFs cultured at NX levels under 0% strain condition to investigate responses induced by culturing CFs in non-physiological NX environments, a standard condition for most previous studies on CFs.<fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.22847.015</object-id><label>Figure 5.</label><caption><title>Overview of the experimental design of the present work.</title><p>(<bold>A</bold>) Oxygen changes reproduced in the present work: an incubation at PX; an abrupt reduction to HX environments (1% O<sub>2</sub>) maintained for 24 hr. (<bold>B</bold>) Mechanical stimulation regimes investigated in the present work: a static control at constant 0% strain; a cyclic mechanical strain stimulation at 2% strain and 1 Hz frequency; a cyclic mechanical strain stimulation at 8% strain and 1 Hz frequency. (<bold>C</bold>) Experimental timeline of the experiments performed: cells were seeded on microdevices and allowed to adhere to the culture membranes for 12 hr at PX and 0% strain before starting the combination of environmental stimuli. After 12 hr from the beginning of stimulations, we fixed samples for immunofluorescence analyses and after 24 hr we fixed samples for immunofluorescence analyses and collected supernatants for protein expression quantifications.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.015">http://dx.doi.org/10.7554/eLife.22847.015</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22847-fig5-v3"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.22847.016</object-id><label>Figure 5—figure supplement 1.</label><caption><title>Overview of the microfluidic platform employed in the present work together with control system.</title><p>A microdevice is filled with color dyes to highlight the microfluidic circuits. Blue channels represent the four cell culture chambers, green channel represents the lower circuit flowing below all four culture chambers meant for oxygen conditioning, red channel represent vacuum actuation circuit for application of mechanical strain to cell cultures. A 3D sketch of the cross section of a single culture chamber is shown with the same color code (upper inset). Elements of the control system are also highlighted: vacuum system is actuated by connecting a vacuum source to a switching valve regulating the amount of cyclic vacuum to be delivered to the devices; oxygen conditioning circuit is actuated by connecting a nitrogen gas source to a flowmeter to regulate the flow of deoxygenating gas through the lower conditioning channel (green).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.016">http://dx.doi.org/10.7554/eLife.22847.016</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22847-fig5-figsupp1-v3"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.22847.017</object-id><label>Figure 5—figure supplement 2.</label><caption><title>Numerical modeling and experimental characterization of oxygen conditioning system included in the microdevices employed for the present work.</title><p>(<bold>A</bold>) Spatial distribution of oxygen tension in a culture chamber cross-section upon application of a fixed oxygen tension (0 mmHg) at the lower channel boundaries simulating the flow of deoxygenating nitrogen gas. The side vacuum chamber boundaries are also set at a fixed oxygen tension to simulate cyclic vacuum application. Considering the membrane region, where cells are cultured (<bold>B</bold>), the oxygen tension is uniformly distributed with limited border effects near the channel walls. (<bold>C</bold>) Outline of the lower layer of the microdevices showing conditioning gas inlets and outlets together with numbered culture chambers. (<bold>D</bold>) Experimental measurements of near-membrane oxygen concentrations performed by means of a needle-based oxygen sensor on all four culture chambers of n = 4 microdevices upon application of varying flowrates (5, 15 and 50 ml/min) of gas in the lower conditioning channel. Oxygen levels reach approximately 1% uniformly throughout all four chambers of the microdevices. (<bold>E</bold>) Experimental measurements of near-membrane oxygen concentrations performed on all four culture chambers of n = 4 microdevice with respect to time (one measurement every 3 s). Deoxygenation time constant, representing the application of conditioning gas flowrate, results in the order of seconds; reoxygenation time constant, representing the interruption of conditioning gas flowrate, results in the order of minutes. (<bold>F</bold>) Impact of conditioning gas flowrates on the resulting membrane strain when no vacuum is applied. No membrane strain is observed for 5 ml/min or 15 ml/min flowrates while 50 ml/min gas flowrates cause membrane strain of approximately 2%.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.017">http://dx.doi.org/10.7554/eLife.22847.017</ext-link></p><p><supplementary-material id="SD5-data"><object-id pub-id-type="doi">10.7554/eLife.22847.018</object-id><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>O<sub>2</sub> concentrations data.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22847.018">http://dx.doi.org/10.7554/eLife.22847.018</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-22847-fig5-figsupp2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22847-fig5-figsupp2-v3"/></fig></fig-group></p></sec><sec id="s4-2"><title>Microdevice outline</title><p>The microdevice was fabricated as previously described (<xref ref-type="bibr" rid="bib80">Ugolini et al., 2016</xref>). Briefly, four stretching units are arranged in a single device composed of a thin polydimethylsiloxane (PDMS) membrane sandwiched between two microstructured PDMS layers. <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> shows a picture of the microdevice together with a sketched cross-section of a stretching unit of the device. In each stretching unit, a central culture chamber (blue) is flanked by two actuation chambers (red) connected to a single actuation line, meant for vacuum application and straining of the central membrane. A lower fluidic channel (green), common to all units, is designed for environmental conditioning and flows below each central culture chamber. <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> also shows the stimulation system: microdevices were actuated by a vacuum line for generating mechanical strain and a gas line for controlling oxygen concentrations. As for the vacuum line, programmable electromechanical valves modulated the vacuum to switch cyclically from atmospheric pressure to the desired vacuum pressure (namely −200 mmHg for 2% strain and −600 mmHg for 8% strain, applied for half a cycle at a rate of 1 Hz). The pneumatic stretch system was previously described and validated (<xref ref-type="bibr" rid="bib80">Ugolini et al., 2016</xref>). The flowrate of humidified gas mixture (95% N<sub>2</sub>; 5% CO<sub>2</sub>) was regulated with a flowmeter and delivered to the microdevices through low-permeability gas tubing. Numerical modeling and experimental characterization of the oxygen control system is described in <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>. Numerical models of a 2D cross-section of the microdevice culture chamber show that the spatial distribution of oxygen tension is uniform along the width of the culture membrane, with limited border effect near the side walls (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A,B</xref>). We employed a needle-based, fine-tip (spatial resolution ≈ 50 µm) oxygen sensor adjusted with a micromanipulator (PreSens, Germany) to reach the culture membrane. Measured oxygen concentration values confirm that the culture membrane is conditioned to ≈1% O<sub>2</sub> at varying flowrates and consistently throughout all four culture chambers (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C,D</xref>). The low-oxygen conditioning occurs within seconds, while reoxygenation occurs within minutes (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2E</xref>). Membrane strains upon application of varying gas flowrates were measured as previously described (<xref ref-type="bibr" rid="bib80">Ugolini et al., 2016</xref>). Gas flowrates of 5 ml/min and 15 ml/min do not cause significant membrane strain (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2F</xref>).</p></sec><sec id="s4-3"><title>Cell culture</title><p>Normal human ventricular cardiac fibroblasts from one donor were purchased from Lonza (Lonza Bioscience, Singapore). Cells were cultured in FGM-3 medium (Lonza Bioscience, Singapore) and in a humidified incubator at 90% N<sub>2</sub>, 5% O<sub>2</sub>, 5% CO<sub>2</sub> at all times unless otherwise indicated. Microdevices were autoclave-sterilized, plasma-treated and coated with human fibronectin (Sigma-Aldrich, Singapore) for 30 min at room temperature. Cells were seeded for experiments at a passage number of four. After pre-loading each culture chamber of the microdevices with 80 µl of medium, 20 µl of cell suspension (10<sup>6</sup> cells/ml) were manually injected in the wells of the culture chambers. During experiments, microdevices were kept in humidified chambers to avoid culture medium evaporation.</p></sec><sec id="s4-4"><title>Immunofluorescence</title><p>Cells were fixed with 4% paraformaldehyde in PBS for 10 min. After 15 min of permeabilization with PBS containing 0.5% Triton-X, cells were blocked for 1 hr at room temperature with 3% bovine serum albumin. Cells were then probed overnight at 4°C with the following primary antibodies: anti-collagen I (mouse, AbCam, UK; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_305411">AB_305411</ext-link>), to identify alterations in collagen I in the culture; anti-phospho-Histone-H3 (PHH3, Ser10, rabbit, Santa-Cruz, US; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2233067">AB_2233067</ext-link>), for mitotic cells; anti-YAP (rabbit, Santa-Cruz, US; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2273277">AB_2273277</ext-link>) to localize nuclear or cytoplasmic localization of the YAP/TAZ complex, a mechano-sensing associated transcription factor and main effector of the Hippo proliferative pathway; anti-αSMA (Smooth Muscle Actin, rabbit, AbCam, UK; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2223021">AB_2223021</ext-link>) to identify myofibroblast differentiation from expression and localization of αSMA. CFs cultured under standard culture medium supplemented with 30 ng/ml TGF-β (Sigma-Aldrich, Singapore) were considered positive controls for αSMA stainings. The following secondary antibodies were used for 2 hr at room temperature: goat anti-mouse Alexa Fluor 488 and goat anti-rabbit Alexa Fluor 564 (AbCam, UK). Nuclear staining was performed by incubating cells with DAPI. Negative controls were present for all immunofluorescence stainings.</p></sec><sec id="s4-5"><title>Image processing</title><p>Images were acquired with a Zeiss 710 Confocal microscope. Imaging parameters were not changed during acquisitions. For quantitative analyses of immunofluorescence markers, three images per culture chamber were taken at 10X magnification, thus sampling roughly half of the total area of the culture membrane and screening about 500 cells per replicate. Images were acquired from the central region of the culture membrane. Collagen I analyses were performed by intracellular fluorescence intensity quantification: the intracellular integrated density parameter was calculated by manually drawing outlines of about 50 cells per replicate from images, correcting for background intensity and normalizing for cell area. Cell proliferation analyses were performed by manually counting nuclei positive for PHH3 and dividing by the total number of nuclei (automatically counted) to estimate the fraction of mitotic cells. YAP localization analyses were performed by manually discriminating cytoplasmic or nuclear staining as previously described (<xref ref-type="bibr" rid="bib11">Codelia et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Dupont et al., 2011</xref>) and dividing by the total number of nuclei (automatically counted) to estimate the level of YAP nuclear translocation.</p></sec><sec id="s4-6"><title>Supernatant analyses</title><p>A volume of culture medium (100 µl) was collected per each culture chamber from the microfluidic devices after 24 hr. Supernatants were stored at −80°C prior to analysis. Residual cells and debris in the supernatant were removed by centrifugation. Concentrations of secreted factors in the supernatants were assessed via multiplex bead-based array according to the manufacturer’s instructions (Luminex, Austin, TX). Each measurement was run in duplicate.</p></sec><sec id="s4-7"><title>Statistical analyses</title><p>All data are presented as mean ± SD. Statistical comparisons were performed using GraphPad (Prism) software. All data were initially analyzed for normality using Kolmogorov-Smirnov tests. Two-way ANOVA tests followed by Bonferroni post-hoc tests were applied to determine statistical significance of differences and evaluate synergistic or separate contribution of mechanical strain stimulation and oxygen dynamics stimulation. When data groups did not pass normality tests, non-parametric statistical tests were employed (Kruskal-Wallis test). A p-value lower than 0.05 was considered significant. All data were collected from a pool of six independent experiments with a minimum number of biological replicates of four. We designed the approximate sample size required for the study by performing power analysis based on previously reported data on human cardiac fibroblasts (CF) proliferative responses under mechanical strain (<xref ref-type="bibr" rid="bib80">Ugolini et al., 2016</xref>). In addition, we considered preliminary data obtained from human CFs cultured at different oxygen levels. An effect size was computed from this data (fraction of mitotic PHH3<sup>+</sup> cells under 2% vs. 8% strain: 2.0 ± 0.5 vs. 0.5 ± 0.3; expression of MMPs at physoxia vs. hypoxia: 1.02 ± 0.2 vs. 2.00 ± 0.1 ng/ml). An <italic>a priori</italic> power analysis performed with GPower (v.3.1) software assured that a sample size of n = 4 is sufficient to achieve α = 0.01 and 1-β (power) = 0.90.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>GSU was awarded a PhD Scholarship from the Italian Ministry of Education, supported by funds from InterPolytechnic Doctoral School mobility scholarship and by Progetto Rocca MIT-Italy exchange program. The research was supported by the National Research Foundation (NRF), Prime Minister’s Office, Singapore, under its CREATE programme, Singapore-MIT Alliance for Research and Technology (SMART) BioSystems and Micromechanics (BioSyM) IRG.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>GSU, Conceptualization, Investigation, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>AP, Supervision, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>MR, Supervision, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>GBF, Supervision, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con5"><p>RK, Supervision, Funding acquisition, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con6"><p>MS, Conceptualization, Supervision, Methodology, Funding acquisition, Project administration, Writing—review and editing</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Goss</surname><given-names>JA</given-names></name><name><surname>Cho</surname><given-names>A</given-names></name><name><surname>McCain</surname><given-names>ML</given-names></name><name><surname>Parker</surname><given-names>KK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Microfluidic heart on a chip for higher throughput pharmacological studies</article-title><source>Lab on a Chip</source><volume>13</volume><fpage>3599</fpage><lpage>3608</lpage><pub-id pub-id-type="doi">10.1039/c3lc50350j</pub-id><pub-id pub-id-type="pmid">23807141</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ai</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Gui</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70S6K signaling pathway</article-title><source>International Journal of Clinical and Experimental Pathology</source><volume>8</volume><fpage>12509</fpage><lpage>12516</lpage><pub-id pub-id-type="pmid">26722438</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atance</surname><given-names>J</given-names></name><name><surname>Yost</surname><given-names>MJ</given-names></name><name><surname>Carver</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch</article-title><source>Journal of Cellular Physiology</source><volume>200</volume><fpage>377</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1002/jcp.20034</pub-id><pub-id pub-id-type="pmid">15254965</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baum</surname><given-names>J</given-names></name><name><surname>Duffy</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Fibroblasts and myofibroblasts: what are we talking about?</article-title><source>Journal of Cardiovascular Pharmacology</source><volume>57</volume><fpage>376</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1097/FJC.0b013e3182116e39</pub-id><pub-id pub-id-type="pmid">21297493</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowers</surname><given-names>SL</given-names></name><name><surname>Borg</surname><given-names>TK</given-names></name><name><surname>Baudino</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The dynamics of fibroblast-myocyte-capillary interactions in the heart</article-title><source>Annals of the New York Academy of Sciences</source><volume>1188</volume><fpage>143</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.05094.x</pub-id><pub-id pub-id-type="pmid">20201897</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>RD</given-names></name><name><surname>Jones</surname><given-names>GM</given-names></name><name><surname>Laird</surname><given-names>RE</given-names></name><name><surname>Hudson</surname><given-names>P</given-names></name><name><surname>Long</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts</article-title><source>Biochemical and Biophysical Research Communications</source><volume>362</volume><fpage>200</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.08.003</pub-id><pub-id pub-id-type="pmid">17706606</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butt</surname><given-names>RP</given-names></name><name><surname>Bishop</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Mechanical load enhances the stimulatory effect of serum growth factors on cardiac fibroblast procollagen synthesis</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>29</volume><fpage>1141</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1006/jmcc.1996.0347</pub-id><pub-id pub-id-type="pmid">9160866</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cartledge</surname><given-names>JE</given-names></name><name><surname>Kane</surname><given-names>C</given-names></name><name><surname>Dias</surname><given-names>P</given-names></name><name><surname>Tesfom</surname><given-names>M</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><name><surname>Mckee</surname><given-names>B</given-names></name><name><surname>Al Ayoubi</surname><given-names>S</given-names></name><name><surname>Chester</surname><given-names>A</given-names></name><name><surname>Yacoub</surname><given-names>MH</given-names></name><name><surname>Camelliti</surname><given-names>P</given-names></name><name><surname>Terracciano</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators</article-title><source>Cardiovascular Research</source><volume>105</volume><fpage>260</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvu264</pub-id><pub-id pub-id-type="pmid">25560320</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carver</surname><given-names>W</given-names></name><name><surname>Nagpal</surname><given-names>ML</given-names></name><name><surname>Nachtigal</surname><given-names>M</given-names></name><name><surname>Borg</surname><given-names>TK</given-names></name><name><surname>Terracio</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Collagen expression in mechanically stimulated cardiac fibroblasts</article-title><source>Circulation Research</source><volume>69</volume><fpage>116</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1161/01.RES.69.1.116</pub-id><pub-id pub-id-type="pmid">2054929</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clancy</surname><given-names>RM</given-names></name><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>O'Mahony</surname><given-names>M</given-names></name><name><surname>Izmirly</surname><given-names>P</given-names></name><name><surname>Zavadil</surname><given-names>J</given-names></name><name><surname>Gardner</surname><given-names>L</given-names></name><name><surname>Buyon</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: implications for progression to scarring in autoimmune-associated congenital heart block</article-title><source>Arthritis and Rheumatism</source><volume>56</volume><fpage>4120</fpage><lpage>4131</lpage><pub-id pub-id-type="doi">10.1002/art.23061</pub-id><pub-id pub-id-type="pmid">18050204</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Codelia</surname><given-names>VA</given-names></name><name><surname>Sun</surname><given-names>G</given-names></name><name><surname>Irvine</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Regulation of YAP by mechanical strain through jnk and hippo signaling</article-title><source>Current Biology</source><volume>24</volume><fpage>2012</fpage><lpage>2017</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2014.07.034</pub-id><pub-id pub-id-type="pmid">25127217</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalla Costa</surname><given-names>AP</given-names></name><name><surname>Clemente</surname><given-names>CF</given-names></name><name><surname>Carvalho</surname><given-names>HF</given-names></name><name><surname>Carvalheira</surname><given-names>JB</given-names></name><name><surname>Nadruz</surname><given-names>W</given-names></name><name><surname>Franchini</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>FAK mediates the activation of cardiac fibroblasts induced by mechanical stress through regulation of the mTOR complex</article-title><source>Cardiovascular Research</source><volume>86</volume><fpage>421</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvp416</pub-id><pub-id pub-id-type="pmid">20038548</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dandel</surname><given-names>M</given-names></name><name><surname>Lehmkuhl</surname><given-names>H</given-names></name><name><surname>Knosalla</surname><given-names>C</given-names></name><name><surname>Suramelashvili</surname><given-names>N</given-names></name><name><surname>Hetzer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Strain and strain rate imaging by echocardiography - basic concepts and clinical applicability</article-title><source>Current Cardiology Reviews</source><volume>5</volume><fpage>133</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.2174/157340309788166642</pub-id><pub-id pub-id-type="pmid">20436854</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobaczewski</surname><given-names>M</given-names></name><name><surname>Bujak</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Gonzalez-Quesada</surname><given-names>C</given-names></name><name><surname>Mendoza</surname><given-names>LH</given-names></name><name><surname>Wang</surname><given-names>XF</given-names></name><name><surname>Frangogiannis</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction</article-title><source>Circulation Research</source><volume>107</volume><fpage>418</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.216101</pub-id><pub-id pub-id-type="pmid">20522804</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupont</surname><given-names>S</given-names></name><name><surname>Morsut</surname><given-names>L</given-names></name><name><surname>Aragona</surname><given-names>M</given-names></name><name><surname>Enzo</surname><given-names>E</given-names></name><name><surname>Giulitti</surname><given-names>S</given-names></name><name><surname>Cordenonsi</surname><given-names>M</given-names></name><name><surname>Zanconato</surname><given-names>F</given-names></name><name><surname>Le Digabel</surname><given-names>J</given-names></name><name><surname>Forcato</surname><given-names>M</given-names></name><name><surname>Bicciato</surname><given-names>S</given-names></name><name><surname>Elvassore</surname><given-names>N</given-names></name><name><surname>Piccolo</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Role of YAP/TAZ in mechanotransduction</article-title><source>Nature</source><volume>474</volume><fpage>179</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1038/nature10137</pub-id><pub-id pub-id-type="pmid">21654799</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgley</surname><given-names>AJ</given-names></name><name><surname>Krum</surname><given-names>H</given-names></name><name><surname>Kelly</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β</article-title><source>Cardiovascular Therapeutics</source><volume>30</volume><fpage>e30</fpage><lpage>e40</lpage><pub-id pub-id-type="doi">10.1111/j.1755-5922.2010.00228.x</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eek</surname><given-names>C</given-names></name><name><surname>Grenne</surname><given-names>B</given-names></name><name><surname>Brunvand</surname><given-names>H</given-names></name><name><surname>Aakhus</surname><given-names>S</given-names></name><name><surname>Endresen</surname><given-names>K</given-names></name><name><surname>Smiseth</surname><given-names>OA</given-names></name><name><surname>Edvardsen</surname><given-names>T</given-names></name><name><surname>Skulstad</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Strain echocardiography predicts acute coronary occlusion in patients with non-ST-segment elevation acute coronary syndrome</article-title><source>European Journal of Echocardiography</source><volume>11</volume><fpage>501</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1093/ejechocard/jeq008</pub-id><pub-id pub-id-type="pmid">20185525</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>D</given-names></name><name><surname>Takawale</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Kassiri</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease</article-title><source>Fibrogenesis &amp; Tissue Repair</source><volume>5</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/1755-1536-5-15</pub-id><pub-id pub-id-type="pmid">22943504</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flachskampf</surname><given-names>FA</given-names></name><name><surname>Schmid</surname><given-names>M</given-names></name><name><surname>Rost</surname><given-names>C</given-names></name><name><surname>Achenbach</surname><given-names>S</given-names></name><name><surname>DeMaria</surname><given-names>AN</given-names></name><name><surname>Daniel</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cardiac imaging after myocardial infarction</article-title><source>European Heart Journal</source><volume>32</volume><fpage>272</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehq446</pub-id><pub-id pub-id-type="pmid">21163851</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frangogiannis</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The inflammatory response in myocardial injury, repair, and remodelling</article-title><source>Nature Reviews Cardiology</source><volume>11</volume><fpage>255</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2014.28</pub-id><pub-id pub-id-type="pmid">24663091</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frantz</surname><given-names>S</given-names></name><name><surname>Hofmann</surname><given-names>U</given-names></name><name><surname>Fraccarollo</surname><given-names>D</given-names></name><name><surname>Schäfer</surname><given-names>A</given-names></name><name><surname>Kranepuhl</surname><given-names>S</given-names></name><name><surname>Hagedorn</surname><given-names>I</given-names></name><name><surname>Nieswandt</surname><given-names>B</given-names></name><name><surname>Nahrendorf</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>H</given-names></name><name><surname>Bayer</surname><given-names>B</given-names></name><name><surname>Pachel</surname><given-names>C</given-names></name><name><surname>Schön</surname><given-names>MP</given-names></name><name><surname>Kneitz</surname><given-names>S</given-names></name><name><surname>Bobinger</surname><given-names>T</given-names></name><name><surname>Weidemann</surname><given-names>F</given-names></name><name><surname>Ertl</surname><given-names>G</given-names></name><name><surname>Bauersachs</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction</article-title><source>The FASEB Journal</source><volume>27</volume><fpage>871</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1096/fj.12-214049</pub-id><pub-id pub-id-type="pmid">23159933</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Zeng</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Pang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Suo</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Matrix metalloproteinase 9 secreted by hypoxia cardiac fibroblasts triggers cardiac stem cell migration in vitro</article-title><source>Stem Cells International</source><volume>2015</volume><elocation-id>836390</elocation-id><lpage>12</lpage><pub-id pub-id-type="doi">10.1155/2015/836390</pub-id><pub-id pub-id-type="pmid">25767513</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Chu</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>J</given-names></name><name><surname>Shang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Hypoxia induces cardiac fibroblast proliferation and phenotypic switch: a role for caveolae and caveolin-1/PTEN mediated pathway</article-title><source>Journal of Thoracic Disease</source><volume>6</volume><fpage>1458</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.3978/j.issn.2072-1439.2014.08.31</pub-id><pub-id pub-id-type="pmid">25364523</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonschior</surname><given-names>P</given-names></name><name><surname>Gonschior</surname><given-names>GM</given-names></name><name><surname>Conzen</surname><given-names>PF</given-names></name><name><surname>Hobbhahn</surname><given-names>J</given-names></name><name><surname>Goetz</surname><given-names>AE</given-names></name><name><surname>Peter</surname><given-names>K</given-names></name><name><surname>Brendel</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Myocardial oxygenation and transmural lactate metabolism during experimental acute coronary stenosis in pigs</article-title><source>Basic Research in Cardiology</source><volume>87</volume><fpage>27</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1007/BF00795387</pub-id><pub-id pub-id-type="pmid">1567351</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>QX</given-names></name><name><surname>Tan</surname><given-names>HW</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>WF</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>xing</surname><given-names>WQ</given-names></name><name><surname>wei</surname><given-names>TH</given-names></name><name><surname>feng</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts</article-title><source>Experimental Cell Research</source><volume>318</volume><fpage>2105</fpage><lpage>2115</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2012.06.015</pub-id><pub-id pub-id-type="pmid">22749815</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillén</surname><given-names>I</given-names></name><name><surname>Blanes</surname><given-names>M</given-names></name><name><surname>Gómez-Lechón</surname><given-names>MJ</given-names></name><name><surname>Castell</surname><given-names>JV</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6</article-title><source>The American Journal of Physiology</source><volume>269</volume><fpage>R229</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">7544543</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>XG</given-names></name><name><surname>Uzui</surname><given-names>H</given-names></name><name><surname>Mizuguchi</surname><given-names>T</given-names></name><name><surname>Ueda</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>JZ</given-names></name><name><surname>Lee</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Imidaprilat inhibits matrix metalloproteinase-2 activity in human cardiac fibroblasts induced by interleukin-1beta via NO-dependent pathway</article-title><source>International Journal of Cardiology</source><volume>126</volume><fpage>414</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2007.08.134</pub-id><pub-id pub-id-type="pmid">18192036</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sonodynamic therapy inhibits fibrogenesis in rat cardiac fibroblasts induced by TGF-β1</article-title><source>Cellular Physiology and Biochemistry</source><volume>40</volume><fpage>579</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1159/000452571</pub-id><pub-id pub-id-type="pmid">27889772</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heusch</surname><given-names>G</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Gersh</surname><given-names>B</given-names></name><name><surname>Yellon</surname><given-names>D</given-names></name><name><surname>Böhm</surname><given-names>M</given-names></name><name><surname>Lopaschuk</surname><given-names>G</given-names></name><name><surname>Opie</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cardiovascular remodelling in coronary artery disease and heart failure</article-title><source>The Lancet</source><volume>383</volume><fpage>1933</fpage><lpage>1943</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)60107-0</pub-id><pub-id pub-id-type="pmid">24831770</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoit</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Strain and strain rate echocardiography and coronary artery disease</article-title><source>Circulation: Cardiovascular Imaging</source><volume>4</volume><fpage>179</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1161/CIRCIMAGING.110.959817</pub-id><pub-id pub-id-type="pmid">21406664</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humeres</surname><given-names>C</given-names></name><name><surname>Vivar</surname><given-names>R</given-names></name><name><surname>Boza</surname><given-names>P</given-names></name><name><surname>Muñoz</surname><given-names>C</given-names></name><name><surname>Bolivar</surname><given-names>S</given-names></name><name><surname>Anfossi</surname><given-names>R</given-names></name><name><surname>Osorio</surname><given-names>JM</given-names></name><name><surname>Olivares-Silva</surname><given-names>F</given-names></name><name><surname>García</surname><given-names>L</given-names></name><name><surname>Díaz-Araya</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cardiac fibroblast cytokine profiles induced by proinflammatory or profibrotic stimuli promote monocyte recruitment and modulate macrophage M1/M2 balance in vitro</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>101</volume><fpage>69</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2016.10.014</pub-id><pub-id pub-id-type="pmid">27983968</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husse</surname><given-names>B</given-names></name><name><surname>Briest</surname><given-names>W</given-names></name><name><surname>Homagk</surname><given-names>L</given-names></name><name><surname>Isenberg</surname><given-names>G</given-names></name><name><surname>Gekle</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cyclical mechanical stretch modulates expression of collagen I and collagen III by PKC and tyrosine kinase in cardiac fibroblasts</article-title><source>AJP: Regulatory, Integrative and Comparative Physiology</source><volume>293</volume><fpage>R1898</fpage><lpage>R1907</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00804.2006</pub-id><pub-id pub-id-type="pmid">17686880</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kania</surname><given-names>G</given-names></name><name><surname>Blyszczuk</surname><given-names>P</given-names></name><name><surname>Eriksson</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mechanisms of cardiac fibrosis in inflammatory heart disease</article-title><source>Trends in Cardiovascular Medicine</source><volume>19</volume><fpage>247</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.tcm.2010.02.005</pub-id><pub-id pub-id-type="pmid">20447565</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Hata</surname><given-names>T</given-names></name><name><surname>Kashima</surname><given-names>Y</given-names></name><name><surname>Usui</surname><given-names>F</given-names></name><name><surname>Morimoto</surname><given-names>H</given-names></name><name><surname>Izawa</surname><given-names>A</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Masumoto</surname><given-names>J</given-names></name><name><surname>Koyama</surname><given-names>J</given-names></name><name><surname>Hongo</surname><given-names>M</given-names></name><name><surname>Noda</surname><given-names>T</given-names></name><name><surname>Nakayama</surname><given-names>J</given-names></name><name><surname>Sagara</surname><given-names>J</given-names></name><name><surname>Taniguchi</surname><given-names>S</given-names></name><name><surname>Ikeda</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury</article-title><source>Circulation</source><volume>123</volume><fpage>594</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.982777</pub-id><pub-id pub-id-type="pmid">21282498</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koizumi</surname><given-names>T</given-names></name><name><surname>Komiyama</surname><given-names>N</given-names></name><name><surname>Nishimura</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>In-Vivo higher plasma levels of Platelet-Derived growth factor and matrix metalloproteinase-9 in coronary artery at the very onset of myocardial infarction with ST-Segment elevation</article-title><source>Annals of Vascular Diseases</source><volume>8</volume><fpage>297</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.3400/avd.oa.15-00057</pub-id><pub-id pub-id-type="pmid">26730254</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krenning</surname><given-names>G</given-names></name><name><surname>Zeisberg</surname><given-names>EM</given-names></name><name><surname>Kalluri</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The origin of fibroblasts and mechanism of cardiac fibrosis</article-title><source>Journal of Cellular Physiology</source><volume>225</volume><fpage>631</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1002/jcp.22322</pub-id><pub-id pub-id-type="pmid">20635395</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leask</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>TGFbeta, cardiac fibroblasts, and the fibrotic response</article-title><source>Cardiovascular Research</source><volume>74</volume><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2006.07.012</pub-id><pub-id pub-id-type="pmid">16919613</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leask</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Potential therapeutic targets for cardiac fibrosis: tgfbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation</article-title><source>Circulation Research</source><volume>106</volume><fpage>1675</fpage><lpage>1680</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.217737</pub-id><pub-id pub-id-type="pmid">20538689</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Qing</surname><given-names>X</given-names></name><name><surname>Xing</surname><given-names>J</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Sheng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Ji</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sp1 mediates a therapeutic role of MiR-7a/b in angiotensin II-Induced cardiac fibrosis via mechanism involving the TGF-β and MAPKs pathways in cardiac fibroblasts</article-title><source>PLoS One</source><volume>10</volume><elocation-id>e0125513</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0125513</pub-id><pub-id pub-id-type="pmid">25923922</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>XD</given-names></name><name><surname>Wang</surname><given-names>XH</given-names></name><name><surname>Jin</surname><given-names>HJ</given-names></name><name><surname>Chen</surname><given-names>LY</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Mechanical stretch induces mitochondria-dependent apoptosis in neonatal rat cardiomyocytes and G2/M accumulation in cardiac fibroblasts</article-title><source>Cell Research</source><volume>14</volume><fpage>16</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1038/sj.cr.7290198</pub-id><pub-id pub-id-type="pmid">15040886</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lijnen</surname><given-names>PJ</given-names></name><name><surname>Petrov</surname><given-names>VV</given-names></name><name><surname>Fagard</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Induction of cardiac fibrosis by transforming growth factor-beta(1)</article-title><source>Molecular Genetics and Metabolism</source><volume>71</volume><fpage>418</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1006/mgme.2000.3032</pub-id><pub-id pub-id-type="pmid">11001836</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindner</surname><given-names>D</given-names></name><name><surname>Zietsch</surname><given-names>C</given-names></name><name><surname>Tank</surname><given-names>J</given-names></name><name><surname>Sossalla</surname><given-names>S</given-names></name><name><surname>Fluschnik</surname><given-names>N</given-names></name><name><surname>Hinrichs</surname><given-names>S</given-names></name><name><surname>Maier</surname><given-names>L</given-names></name><name><surname>Poller</surname><given-names>W</given-names></name><name><surname>Blankenberg</surname><given-names>S</given-names></name><name><surname>Schultheiss</surname><given-names>H-P</given-names></name><name><surname>Tschöpe</surname><given-names>C</given-names></name><name><surname>Westermann</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cardiac fibroblasts support cardiac inflammation in heart failure</article-title><source>Basic Research in Cardiology</source><volume>109</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1007/s00395-014-0428-7</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Meng</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Ahokas</surname><given-names>RA</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Platelet-derived growth factor blockade on cardiac remodeling following infarction</article-title><source>Molecular and Cellular Biochemistry</source><volume>397</volume><fpage>295</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1007/s11010-014-2197-x</pub-id><pub-id pub-id-type="pmid">25148874</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsano</surname><given-names>A</given-names></name><name><surname>Conficconi</surname><given-names>C</given-names></name><name><surname>Lemme</surname><given-names>M</given-names></name><name><surname>Occhetta</surname><given-names>P</given-names></name><name><surname>Gaudiello</surname><given-names>E</given-names></name><name><surname>Votta</surname><given-names>E</given-names></name><name><surname>Cerino</surname><given-names>G</given-names></name><name><surname>Redaelli</surname><given-names>A</given-names></name><name><surname>Rasponi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues</article-title><source>Lab Chip</source><volume>16</volume><fpage>599</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1039/C5LC01356A</pub-id><pub-id pub-id-type="pmid">26758922</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollema</surname><given-names>SA</given-names></name><name><surname>Delgado</surname><given-names>V</given-names></name><name><surname>Bertini</surname><given-names>M</given-names></name><name><surname>Antoni</surname><given-names>ML</given-names></name><name><surname>Boersma</surname><given-names>E</given-names></name><name><surname>Holman</surname><given-names>ER</given-names></name><name><surname>Stokkel</surname><given-names>MP</given-names></name><name><surname>van der Wall</surname><given-names>EE</given-names></name><name><surname>Schalij</surname><given-names>MJ</given-names></name><name><surname>Bax</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Viability assessment with global left ventricular longitudinal strain predicts recovery of left ventricular function after acute myocardial infarction</article-title><source>Circulation: Cardiovascular Imaging</source><volume>3</volume><fpage>15</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1161/CIRCIMAGING.108.802785</pub-id><pub-id pub-id-type="pmid">19820202</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morishita</surname><given-names>T</given-names></name><name><surname>Uzui</surname><given-names>H</given-names></name><name><surname>Mitsuke</surname><given-names>Y</given-names></name><name><surname>Arakawa</surname><given-names>K</given-names></name><name><surname>Amaya</surname><given-names>N</given-names></name><name><surname>Kaseno</surname><given-names>K</given-names></name><name><surname>Ishida</surname><given-names>K</given-names></name><name><surname>Nakaya</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>JD</given-names></name><name><surname>Tada</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Predictive utility of the changes in matrix metalloproteinase-2 in the early phase for left ventricular reverse remodeling after an acute myocardial infarction</article-title><source>Journal of the American Heart Association</source><volume>4</volume><elocation-id>e001359</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.114.001359</pub-id><pub-id pub-id-type="pmid">25616975</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosqueira</surname><given-names>D</given-names></name><name><surname>Pagliari</surname><given-names>S</given-names></name><name><surname>Uto</surname><given-names>K</given-names></name><name><surname>Ebara</surname><given-names>M</given-names></name><name><surname>Romanazzo</surname><given-names>S</given-names></name><name><surname>Escobedo-Lucea</surname><given-names>C</given-names></name><name><surname>Nakanishi</surname><given-names>J</given-names></name><name><surname>Taniguchi</surname><given-names>A</given-names></name><name><surname>Franzese</surname><given-names>O</given-names></name><name><surname>Di Nardo</surname><given-names>P</given-names></name><name><surname>Goumans</surname><given-names>MJ</given-names></name><name><surname>Traversa</surname><given-names>E</given-names></name><name><surname>Pinto-do-Ó</surname><given-names>P</given-names></name><name><surname>Aoyagi</surname><given-names>T</given-names></name><name><surname>Forte</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Hippo pathway effectors control cardiac progenitor cell fate by acting as dynamic sensors of substrate mechanics and nanostructure</article-title><source>ACS Nano</source><volume>8</volume><fpage>2033</fpage><lpage>2047</lpage><pub-id pub-id-type="doi">10.1021/nn4058984</pub-id><pub-id pub-id-type="pmid">24483337</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nahrendorf</surname><given-names>M</given-names></name><name><surname>Pittet</surname><given-names>MJ</given-names></name><name><surname>Swirski</surname><given-names>FK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Monocytes: protagonists of infarct inflammation and repair after myocardial infarction</article-title><source>Circulation</source><volume>121</volume><fpage>2437</fpage><lpage>2445</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.916346</pub-id><pub-id pub-id-type="pmid">20530020</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>H</given-names></name><name><surname>Takemura</surname><given-names>G</given-names></name><name><surname>Kosai</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Esaki</surname><given-names>M</given-names></name><name><surname>Yuge</surname><given-names>K</given-names></name><name><surname>Miyata</surname><given-names>S</given-names></name><name><surname>Maruyama</surname><given-names>R</given-names></name><name><surname>Mikami</surname><given-names>A</given-names></name><name><surname>Minatoguchi</surname><given-names>S</given-names></name><name><surname>Fujiwara</surname><given-names>T</given-names></name><name><surname>Fujiwara</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure</article-title><source>Circulation</source><volume>111</volume><fpage>2430</fpage><lpage>2437</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000165066.71481.8E</pub-id><pub-id pub-id-type="pmid">15867170</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transforming growth factor β1 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts</article-title><source>PLoS One</source><volume>8</volume><elocation-id>e60335</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0060335</pub-id><pub-id pub-id-type="pmid">23560091</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papizan</surname><given-names>JB</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Hippo in the path to heart repair</article-title><source>Circulation Research</source><volume>115</volume><fpage>332</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.114.304389</pub-id><pub-id pub-id-type="pmid">25035132</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavesi</surname><given-names>A</given-names></name><name><surname>Adriani</surname><given-names>G</given-names></name><name><surname>Rasponi</surname><given-names>M</given-names></name><name><surname>Zervantonakis</surname><given-names>IK</given-names></name><name><surname>Fiore</surname><given-names>GB</given-names></name><name><surname>Kamm</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Controlled electromechanical cell stimulation on-a-chip</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>11800</elocation-id><pub-id pub-id-type="doi">10.1038/srep11800</pub-id><pub-id pub-id-type="pmid">26135970</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Carretero</surname><given-names>OA</given-names></name><name><surname>Peterson</surname><given-names>EL</given-names></name><name><surname>Rhaleb</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts</article-title><source>AJP: Heart and Circulatory Physiology</source><volume>298</volume><fpage>H1357</fpage><lpage>H1364</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00464.2009</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrov</surname><given-names>VV</given-names></name><name><surname>Fagard</surname><given-names>RH</given-names></name><name><surname>Lijnen</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts</article-title><source>Hypertension</source><volume>39</volume><fpage>258</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1161/hy0202.103268</pub-id><pub-id pub-id-type="pmid">11847194</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeffer</surname><given-names>MA</given-names></name><name><surname>Braunwald</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Ventricular remodeling after myocardial infarction. experimental observations and clinical implications</article-title><source>Circulation</source><volume>81</volume><fpage>1161</fpage><lpage>1172</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.81.4.1161</pub-id><pub-id pub-id-type="pmid">2138525</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picard</surname><given-names>MH</given-names></name><name><surname>Wilkins</surname><given-names>GT</given-names></name><name><surname>Ray</surname><given-names>PA</given-names></name><name><surname>Weyman</surname><given-names>AE</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Natural history of left ventricular size and function after acute myocardial infarction. assessment and prediction by echocardiographic endocardial surface mapping</article-title><source>Circulation</source><volume>82</volume><fpage>484</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.82.2.484</pub-id><pub-id pub-id-type="pmid">2372895</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>KE</given-names></name><name><surname>Turner</surname><given-names>NA</given-names></name><name><surname>O'Regan</surname><given-names>DJ</given-names></name><name><surname>Ball</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin</article-title><source>Cardiovascular Research</source><volume>64</volume><fpage>507</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2004.07.020</pub-id><pub-id pub-id-type="pmid">15537504</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>KE</given-names></name><name><surname>Turner</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cardiac fibroblasts: at the heart of myocardial remodeling</article-title><source>Pharmacology &amp; Therapeutics</source><volume>123</volume><fpage>255</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2009.05.002</pub-id><pub-id pub-id-type="pmid">19460403</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhaleb</surname><given-names>NE</given-names></name><name><surname>Pokharel</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>UC</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Peterson</surname><given-names>E</given-names></name><name><surname>Harding</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>XP</given-names></name><name><surname>Carretero</surname><given-names>OA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>N-acetyl-Ser-Asp-Lys-Pro inhibits interleukin-1β-mediated matrix metalloproteinase activation in cardiac fibroblasts</article-title><source>Pflügers Archiv - European Journal of Physiology</source><volume>465</volume><fpage>1487</fpage><lpage>1495</lpage><pub-id pub-id-type="doi">10.1007/s00424-013-1262-8</pub-id><pub-id pub-id-type="pmid">23652767</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riches</surname><given-names>K</given-names></name><name><surname>Morley</surname><given-names>ME</given-names></name><name><surname>Turner</surname><given-names>NA</given-names></name><name><surname>O'Regan</surname><given-names>DJ</given-names></name><name><surname>Ball</surname><given-names>SG</given-names></name><name><surname>Peers</surname><given-names>C</given-names></name><name><surname>Porter</surname><given-names>KE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>47</volume><fpage>391</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.06.002</pub-id><pub-id pub-id-type="pmid">19523958</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roubille</surname><given-names>F</given-names></name><name><surname>Busseuil</surname><given-names>D</given-names></name><name><surname>Merlet</surname><given-names>N</given-names></name><name><surname>Kritikou</surname><given-names>EA</given-names></name><name><surname>Rhéaume</surname><given-names>E</given-names></name><name><surname>Tardif</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Investigational drugs targeting cardiac fibrosis</article-title><source>Expert Review of Cardiovascular Therapy</source><volume>12</volume><fpage>111</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1586/14779072.2013.839942</pub-id><pub-id pub-id-type="pmid">24218990</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Khanna</surname><given-names>S</given-names></name><name><surname>Bickerstaff</surname><given-names>AA</given-names></name><name><surname>Subramanian</surname><given-names>SV</given-names></name><name><surname>Atalay</surname><given-names>M</given-names></name><name><surname>Bierl</surname><given-names>M</given-names></name><name><surname>Pendyala</surname><given-names>S</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Venojarvi</surname><given-names>M</given-names></name><name><surname>Strauch</surname><given-names>A</given-names></name><name><surname>Orosz</surname><given-names>CG</given-names></name><name><surname>Sen</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1)</article-title><source>Circulation Research</source><volume>92</volume><fpage>264</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000056770.30922.E6</pub-id><pub-id pub-id-type="pmid">12595337</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santiago</surname><given-names>JJ</given-names></name><name><surname>Dangerfield</surname><given-names>AL</given-names></name><name><surname>Rattan</surname><given-names>SG</given-names></name><name><surname>Bathe</surname><given-names>KL</given-names></name><name><surname>Cunnington</surname><given-names>RH</given-names></name><name><surname>Raizman</surname><given-names>JE</given-names></name><name><surname>Bedosky</surname><given-names>KM</given-names></name><name><surname>Freed</surname><given-names>DH</given-names></name><name><surname>Kardami</surname><given-names>E</given-names></name><name><surname>Dixon</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts</article-title><source>Developmental Dynamics</source><volume>239</volume><fpage>1573</fpage><lpage>1584</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22280</pub-id><pub-id pub-id-type="pmid">20503355</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroer</surname><given-names>AK</given-names></name><name><surname>Merryman</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease</article-title><source>Journal of Cell Science</source><volume>128</volume><fpage>1865</fpage><lpage>1875</lpage><pub-id pub-id-type="doi">10.1242/jcs.162891</pub-id><pub-id pub-id-type="pmid">25918124</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>CK</given-names></name><name><surname>Khanna</surname><given-names>S</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Perceived hyperoxia: oxygen-induced remodeling of the reoxygenated heart</article-title><source>Cardiovascular Research</source><volume>71</volume><fpage>280</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2006.01.003</pub-id><pub-id pub-id-type="pmid">16483558</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>CK</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Oxygenation state as a driver of myofibroblast differentiation and wound contraction: hypoxia impairs wound closure</article-title><source>Journal of Investigative Dermatology</source><volume>130</volume><fpage>2701</fpage><lpage>2703</lpage><pub-id pub-id-type="doi">10.1038/jid.2010.316</pub-id><pub-id pub-id-type="pmid">21068734</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinde</surname><given-names>AV</given-names></name><name><surname>Frangogiannis</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fibroblasts in myocardial infarction: a role in inflammation and repair</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>70</volume><fpage>74</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.11.015</pub-id><pub-id pub-id-type="pmid">24321195</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siwik</surname><given-names>DA</given-names></name><name><surname>Chang</surname><given-names>DL</given-names></name><name><surname>Colucci</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro</article-title><source>Circulation Research</source><volume>86</volume><fpage>1259</fpage><lpage>1265</lpage><pub-id pub-id-type="doi">10.1161/01.RES.86.12.1259</pub-id><pub-id pub-id-type="pmid">10864917</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stawowy</surname><given-names>P</given-names></name><name><surname>Margeta</surname><given-names>C</given-names></name><name><surname>Kallisch</surname><given-names>H</given-names></name><name><surname>Seidah</surname><given-names>NG</given-names></name><name><surname>Chrétien</surname><given-names>M</given-names></name><name><surname>Fleck</surname><given-names>E</given-names></name><name><surname>Graf</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase</article-title><source>Cardiovascular Research</source><volume>63</volume><fpage>87</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2004.03.010</pub-id><pub-id pub-id-type="pmid">15194465</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talman</surname><given-names>V</given-names></name><name><surname>Ruskoaho</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration</article-title><source>Cell and Tissue Research</source><volume>365</volume><fpage>563</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1007/s00441-016-2431-9</pub-id><pub-id pub-id-type="pmid">27324127</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamamori</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>H</given-names></name><name><surname>Hiroe</surname><given-names>M</given-names></name><name><surname>Marumo</surname><given-names>F</given-names></name><name><surname>Hata</surname><given-names>RI</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Stimulation of collagen synthesis in rat cardiac fibroblasts by exposure to hypoxic culture conditions and suppression of the effect by natriuretic peptides</article-title><source>Cell Biology International</source><volume>21</volume><fpage>175</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1006/cbir.1997.0130</pub-id><pub-id pub-id-type="pmid">9151994</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tennant</surname><given-names>R</given-names></name><name><surname>Wiggers</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="1935">1935</year><article-title>The effect of coronary occlusion on myocardial contraction</article-title><source>Am. J. Physiol. - Hear. Circ. Physiol</source><volume>112</volume><fpage>351</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/S0002-8703(35)90365-9</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomasek</surname><given-names>JJ</given-names></name><name><surname>Gabbiani</surname><given-names>G</given-names></name><name><surname>Hinz</surname><given-names>B</given-names></name><name><surname>Chaponnier</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Myofibroblasts and mechano-regulation of connective tissue remodelling</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>3</volume><fpage>349</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1038/nrm809</pub-id><pub-id pub-id-type="pmid">11988769</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsoporis</surname><given-names>JN</given-names></name><name><surname>Izhar</surname><given-names>S</given-names></name><name><surname>Proteau</surname><given-names>G</given-names></name><name><surname>Slaughter</surname><given-names>G</given-names></name><name><surname>Parker</surname><given-names>TG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>52</volume><fpage>464</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2011.08.015</pub-id><pub-id pub-id-type="pmid">21889514</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>NA</given-names></name><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Warburton</surname><given-names>P</given-names></name><name><surname>O'Regan</surname><given-names>DJ</given-names></name><name><surname>Ball</surname><given-names>SG</given-names></name><name><surname>Porter</surname><given-names>KE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Interleukin-1alpha stimulates proinflammatory cytokine expression in human cardiac myofibroblasts</article-title><source>AJP: Heart and Circulatory Physiology</source><volume>297</volume><fpage>H1117</fpage><lpage>H1127</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00372.2009</pub-id><pub-id pub-id-type="pmid">19648252</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>NA</given-names></name><name><surname>Mughal</surname><given-names>RS</given-names></name><name><surname>Warburton</surname><given-names>P</given-names></name><name><surname>O'Regan</surname><given-names>DJ</given-names></name><name><surname>Ball</surname><given-names>SG</given-names></name><name><surname>Porter</surname><given-names>KE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones</article-title><source>Cardiovascular Research</source><volume>76</volume><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2007.06.003</pub-id><pub-id pub-id-type="pmid">17612514</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Effects of interleukin-1 on cardiac fibroblast function: relevance to post-myocardial infarction remodelling</article-title><source>Vascular Pharmacology</source><volume>60</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.vph.2013.06.002</pub-id><pub-id pub-id-type="pmid">23806284</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>94</volume><fpage>189</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.11.002</pub-id><pub-id pub-id-type="pmid">26542796</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyagi</surname><given-names>SC</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name><name><surname>Pikes</surname><given-names>D</given-names></name><name><surname>Marcello</surname><given-names>A</given-names></name><name><surname>Mujumdar</surname><given-names>VS</given-names></name><name><surname>Smiley</surname><given-names>LM</given-names></name><name><surname>Moore</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells</article-title><source>Journal of Cellular Physiology</source><volume>176</volume><fpage>374</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-4652(199808)176:2&lt;374::AID-JCP16&gt;3.0.CO;2-3</pub-id><pub-id pub-id-type="pmid">9648925</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ugolini</surname><given-names>GS</given-names></name><name><surname>Rasponi</surname><given-names>M</given-names></name><name><surname>Pavesi</surname><given-names>A</given-names></name><name><surname>Santoro</surname><given-names>R</given-names></name><name><surname>Kamm</surname><given-names>R</given-names></name><name><surname>Fiore</surname><given-names>GB</given-names></name><name><surname>Pesce</surname><given-names>M</given-names></name><name><surname>Soncini</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>On-chip assessment of human primary cardiac fibroblasts proliferative responses to uniaxial cyclic mechanical strain</article-title><source>Biotechnology and Bioengineering</source><volume>113</volume><fpage>859</fpage><lpage>869</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/26444553">http://www.ncbi.nlm.nih.gov/pubmed/26444553</ext-link><pub-id pub-id-type="doi">10.1002/bit.25847</pub-id><pub-id pub-id-type="pmid">26444553</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uzel</surname><given-names>SG</given-names></name><name><surname>Pavesi</surname><given-names>A</given-names></name><name><surname>Kamm</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Microfabrication and microfluidics for muscle tissue models</article-title><source>Progress in Biophysics and Molecular Biology</source><volume>115</volume><fpage>279</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2014.08.013</pub-id><pub-id pub-id-type="pmid">25175338</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Amerongen</surname><given-names>MJ</given-names></name><name><surname>Harmsen</surname><given-names>MC</given-names></name><name><surname>van Rooijen</surname><given-names>N</given-names></name><name><surname>Petersen</surname><given-names>AH</given-names></name><name><surname>van Luyn</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice</article-title><source>The American Journal of Pathology</source><volume>170</volume><fpage>818</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2007.060547</pub-id><pub-id pub-id-type="pmid">17322368</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Nieuwenhoven</surname><given-names>FA</given-names></name><name><surname>Hemmings</surname><given-names>KE</given-names></name><name><surname>Porter</surname><given-names>KE</given-names></name><name><surname>Turner</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Combined effects of interleukin-1α and transforming growth factor-β1 on modulation of human cardiac fibroblast function</article-title><source>Matrix Biology</source><volume>32</volume><fpage>399</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.matbio.2013.03.008</pub-id><pub-id pub-id-type="pmid">23583823</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vartdal</surname><given-names>T</given-names></name><name><surname>Brunvand</surname><given-names>H</given-names></name><name><surname>Pettersen</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>HJ</given-names></name><name><surname>Lyseggen</surname><given-names>E</given-names></name><name><surname>Helle-Valle</surname><given-names>T</given-names></name><name><surname>Skulstad</surname><given-names>H</given-names></name><name><surname>Ihlen</surname><given-names>H</given-names></name><name><surname>Edvardsen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Early prediction of infarct size by strain doppler echocardiography after coronary reperfusion</article-title><source>Journal of the American College of Cardiology</source><volume>49</volume><fpage>1715</fpage><lpage>1721</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2006.12.047</pub-id><pub-id pub-id-type="pmid">17448374</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivar</surname><given-names>R</given-names></name><name><surname>Humeres</surname><given-names>C</given-names></name><name><surname>Muñoz</surname><given-names>C</given-names></name><name><surname>Boza</surname><given-names>P</given-names></name><name><surname>Bolivar</surname><given-names>S</given-names></name><name><surname>Tapia</surname><given-names>F</given-names></name><name><surname>Lavandero</surname><given-names>S</given-names></name><name><surname>Chiong</surname><given-names>M</given-names></name><name><surname>Diaz-Araya</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>FoxO1 mediates TGF-beta1-dependent cardiac myofibroblast differentiation</article-title><source>Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research</source><volume>1863</volume><fpage>128</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2015.10.019</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winegrad</surname><given-names>S</given-names></name><name><surname>Henrion</surname><given-names>D</given-names></name><name><surname>Rappaport</surname><given-names>L</given-names></name><name><surname>Samuel</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Self-protection by cardiac myocytes against hypoxia and hyperoxia</article-title><source>Circulation Research</source><volume>85</volume><fpage>690</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1161/01.RES.85.8.690</pub-id><pub-id pub-id-type="pmid">10521242</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Sheng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Ji</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro</article-title><source>Drug Design, Development and Therapy</source><volume>10</volume><fpage>1267</fpage><lpage>1277</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S104925</pub-id><pub-id pub-id-type="pmid">27099472</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xin</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Sutherland</surname><given-names>LB</given-names></name><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>McAnally</surname><given-names>J</given-names></name><name><surname>Porrello</surname><given-names>ER</given-names></name><name><surname>Mahmoud</surname><given-names>AI</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Shelton</surname><given-names>JM</given-names></name><name><surname>Richardson</surname><given-names>JA</given-names></name><name><surname>Sadek</surname><given-names>HA</given-names></name><name><surname>Bassel-Duby</surname><given-names>R</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Hippo pathway effector yap promotes cardiac regeneration</article-title><source>PNAS</source><volume>110</volume><fpage>13839</fpage><lpage>13844</lpage><pub-id pub-id-type="doi">10.1073/pnas.1313192110</pub-id><pub-id pub-id-type="pmid">23918388</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>T</given-names></name><name><surname>Sekiguchi</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Tomaru</surname><given-names>K</given-names></name><name><surname>Arai</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Nagai</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts</article-title><source>Journal of Cardiac Failure</source><volume>276</volume><fpage>44</fpage><lpage>H1976</lpage><pub-id pub-id-type="doi">10.1016/S1071-9164(99)91145-4</pub-id><pub-id pub-id-type="pmid">10362677</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Mende</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences</article-title><source>AJP: Heart and Circulatory Physiology</source><volume>303</volume><fpage>H1385</fpage><lpage>H1396</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01167.2011</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>V</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Ahokas</surname><given-names>RA</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Platelet-derived growth factor involvement in myocardial remodeling following infarction</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>51</volume><fpage>830</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2011.06.023</pub-id><pub-id pub-id-type="pmid">21767547</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.22847.019</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Vunjak-Novakovic</surname><given-names>Gordana</given-names></name><role>Reviewing editor</role><aff><institution>Columbia University</institution>, <country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Human cardiac fibroblasts adaptive responses to controlled combined mechanical strain and oxygen changes&quot; for consideration by <italic>eLife</italic>. Your article has been favorably evaluated by Fiona Watt (Senior Editor) and two reviewers, one of whom, Gordana Vunjak-Novakovic (Reviewer #1), is a member of our Board of Reviewing Editors.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>The authors model the formation of fibrotic scar in human myocardium, using a simple microfluidic device to subject human cardiac fibroblasts to controllable levels of oxygen and mechanical strain. The central idea is to investigate the combinations of these two important signals that correspond to the healthy tissue, ischemic tissue and reoxygenated myocardium. Three known determining features of cardiac fibrosis were evaluated: remodeling of the extracellular matrix (collagen I, MMPs), proliferation of cardiac fibroblasts (mitotic cells, PDGF), and secretion of cytokines (inflammatory, pro-fibrotic). The main finding is that the combination of hypoxia (1% oxygen) and reduced contractility (2% strain) induced fibrotic responses in cardiac fibroblasts: production of MMPs and secretion of inflammatory and pro-fibrotic cytokines.</p><p>Summary:</p><p>The reviewers find that the paper describes an interesting in vitro model of cardiac fibrosis, by studying the responses of cardiac fibroblasts to combinations of mechanical strain and oxygen levels. The main criticism is that the study lacks mechanical insights.</p><p>Essential revisions:</p><p>The reviewers raise a number of concerns that must be adequately addressed before the paper can be further considered for publication in <italic>eLife</italic>. Some of the required revisions will likely require further experimentation within the framework of the presented studies and techniques.</p><p>1) The validation of the model is not described. While the measured data qualitatively correspond to the readouts associated with cardiac fibrosis, the quantitative correlations are lacking. The model of hypoxia/reoxygenation appears oversimplified, as this condition has an important timing component that is not captured. As this model is not critical to the main findings of the study, it should be either rationalized or eliminated.</p><p>2) The authors should discuss the selection of experimental parameters in more detail, in the context of cardiac physiology and pathology. For example, the reduced strain is a consequence of fibrosis, not its cause, and the explanation of how exactly the pathological changes were modeled would be of interest.</p><p>3) The model involves only cardiac fibroblasts, studied in isolation. It is unclear how much the measured responses of cardiac fibroblasts could be affected by the presence of other cells in the heart, both directly (e.g., contractility) and indirectly (paracrine signals).</p><p>4) Some of the figures and the table repeat the same data. <xref ref-type="table" rid="tbl1">Table 1</xref> and <xref ref-type="fig" rid="fig4">Figure 4</xref> are summaries. <xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig2">2</xref> and <xref ref-type="fig" rid="fig3">3</xref> contain heat maps that are summaries of the data in the bar charts. <xref ref-type="fig" rid="fig5">Figure 5</xref> is technical description (would be better as supplementary). The data in <xref ref-type="fig" rid="fig1">Figures 1</xref>, <xref ref-type="fig" rid="fig2">2</xref> and <xref ref-type="fig" rid="fig3">3</xref> contain protein secretion data from a multiplex Luminex array – i.e. multiple readouts from a simple experiment but organised into separate figures. All of these data could be condensed and consolidated.</p><p>5) There is no information on myofibroblast differentiation (e.g. ICC of α-SMA) which would be interesting to know as myofibroblast phenotype is of key importance in regulating ECM turnover and cardiac remodeling.</p><p>6) The numbers of cell donors, independent experiments, and biological replicates should be specified for all experimental data.</p><p>7) The reference list lacks important information (e.g. volume and page numbers).</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.22847.020</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p><italic>Essential revisions:</italic> </p><p><italic>The reviewers raise a number of concerns that must be adequately addressed before the paper can be further considered for publication in eLife. Some of the required revisions will likely require further experimentation within the framework of the presented studies and techniques.</italic> </p><p><italic>1) The validation of the model is not described. While the measured data qualitatively correspond to the readouts associated with cardiac fibrosis, the quantitative correlations are lacking. The model of hypoxia/reoxygenation appears oversimplified, as this condition has an important timing component that is not captured. As this model is not critical to the main findings of the study, it should be either rationalized or eliminated.</italic> </p><p>We agree with this comment and thank the reviewers for suggesting ways to improve the description of our approach in the context of current standard fibrotic models. Current literature shows how the most widely accepted in vitromodels for investigating cardiac fibroblasts responses to a fibrotic environment involve the stimulation of cultures with soluble pro-fibrotic or inflammatory cytokines (the most relevant being TGF-β, Angiotensin II and interleukins) (see Talman, et al., 2016; Fan, et al., 2012 referenced in the manuscript). We quantitatively correlated the outcomes of our model to others in the literature, selected by following these criteria: choosing only models involving early responses and showing data obtained from protein expression assays or immunofluorescence (except for data regarding cell proliferation). These comparisons are now listed in <xref ref-type="table" rid="tbl2">Table 2 and a</xref> supplementary new graph (<xref ref-type="supplementary-material" rid="SD4-data">Table 2—source data 1</xref>) displays quantitative changes observed in standard and on-chip model according to the marker of interest. They allowed us to highlight pathological aspects that the model is efficiently capturing and behaviors that are not induced by tuning the microenvironment. This analysis revealed that CFs responses elicited in our model are in agreement with the ones observed in the existing models in both qualitative and quantitative terms. On the other hand, we also highlight that our model is the first to capture CF secretion of PDGF (a highly relevant factor in post-injury myocardial response), contrary to standard models. Also, we found that two inflammatory cytokines associated with cardiac injury and fibrosis (TNF-α and IL-6) are not upregulated by environmental stimuli, contrary to some reports that employ soluble pro-fibrotic stimulation. A fragment covering these points has been now added to the manuscript Discussion (tenth paragraph).</p><p>While we did not provide extensive quantitative correlations to in vivo data due to the dramatic differences in assay types (e.g. serum/plasma levels of markers) and experimental contexts, we highlighted interesting correlations with, for instance, early increased levels of MMPs or PDGF in patients (Discussion, tenth paragraph).</p><p>We also agree with the comment that our hypoxia-reperfusion model has limited impact on the main findings of our work. It was indeed previously included in the manuscript to serve as a demonstration of the capability of our novel microsystem. We have removed results of the hypoxia-reperfusion condition from the text and figures of the revised version of the manuscript.</p><p><italic>2) The authors should discuss the selection of experimental parameters in more detail, in the context of cardiac physiology and pathology. For example, the reduced strain is a consequence of fibrosis, not its cause, and the explanation of how exactly the pathological changes were modeled would be of interest.</italic> </p><p>We agree with the reviewers about the lack of a proper context for the selection of the model parameters within the biological problem investigated. We added a paragraph to the Introduction covering in detail the choice of oxygen levels, mechanical strain levels and timings.</p><p>We agree with the reviewers that chronic cardiac fibrosis is the cause of myocardial scar formation and hence local reduced contractility. However, this event is the result of a slower tissue response, a culmination of the injury-related myocardial remodeling (inflammatory, proliferative and maturation phases) and occurring over a timeframe widely described as lasting weeks. In its current form and experimental exploitation, our model is not meant to account for and recapitulate such long-term phenomena in vitro. Rather, we focused on the fundamental cellular responses initiating the pathology. These responses have been shown (in our data and previous studies, see Turner, et al., 2007; Turner et al., 2009; Ugolini, et al., 2016, Van Nieuwenhoven, et al., 2013) to be evoked at early timeframes (in the acute phase of hours or days). in vivo human studies have also reported how, for instance, remodeling factors (e.g., MMPs) peak 24h post-injury (see Morishita, et al., 2015). We therefore revised the text in order to better describe our work as a model of early acute CF responses rather than a model of chronic cardiac fibrosis.</p><p>In this early and acute pathological context, it has been observed in patients that the myocardium undergoes abrupt mechanical changes immediately following injury (0-48h). Cardiac imaging studies agree in the interpretation that global strains are abruptly reduced shortly after myocardial insult (see Flachskampf et al., 2011; Hoit, 2011; Mollema et al., 2010). Quantitatively, strain values recorded depend on imaging algorithms and vary significantly throughout the heart. It is therefore difficult to directly translate them in vitro. The differences between healthy myocardial strains and ischemic/injured regions have been however reported to be 2-4 fold lower: Vartdal, et al., (2007) described an ischemic peak systolic strain of approximately 4% versus a physiological values of approximately 13%; Dandel, et al. (2009) report pathological values lower than 3% vs. physiological values of 10%. Our choice of mechanical strain values (2% strain, 8% strain and static control) was guided by such imaging studies and is meant to be in line with previous observations on CFs different responses to different strain regimes (Ugolini, et al., 2016) in order to provide comparable data.</p><p>In terms of oxygen levels, there is wide agreement on the fact that in vivohealthymyocardial tissue is characterized by an oxygen concentration of 5-6% (see Sen et al., 2006; Winegrad, et al., 1999; Gonschior, et al., 1992) and on the fact that upon ischemic cardiac injuries oxygen levels drop to 0-1% due to impaired blood flow (Roy, et al., 2003).</p><p>We hope to have better described our work in the context of cardiac physiology and pathology, particularly in the Introduction where a new paragraph addresses the above previous unclear points (Introduction, last paragraph).</p><p><italic>3) The model involves only cardiac fibroblasts, studied in isolation. It is unclear how much the measured responses of cardiac fibroblasts could be affected by the presence of other cells in the heart, both directly (e.g., contractility) and indirectly (paracrine signals).</italic> </p><p>We thank the reviewers for suggesting a more detailed discussion of the missing components of the model compared to in vivoheart homeostasis. We added a more detailed paragraph in the Discussion (last paragraph; and reported below) that describes how the missing heart cellular actors could influence CF responses. Since our finely tuned mechanical stimulation system accounts for changes in contractility directly and uniformly delivered to cultured CFs, we believe indirect paracrine signals represent the key environmental factors that should be addressed by future studies (e.g., introducing a multi-culture in our model). Indeed, we made use of the comparison with other in vitromodels that employ soluble signals to discuss how additional pathological responses of CFs could be elicited by soluble factors provided by nearby apoptotic cardiac myocytes or infiltrated immune cells.</p><p>“This last missing readout suggests that indirect paracrine action provided by other cellular actors involved in myocardial homeostasis and typically modeled in standard biochemical stimulation approaches is likely to play a role in driving those CF pathological behaviors that are not captured in our model. […] Consequently, improving the current model with the addition of indirect paracrine action by other cellular actors is a potentially promising future direction for this study, expected to lead to a full on-chip recapitulation of early cardiac injury cellular events by building solely on a fine mimicry of the microenvironment rather than on current biochemical stimulation approaches.”</p><p><italic>4) Some of the figures and the table repeat the same data. <xref ref-type="table" rid="tbl1">Table 1</xref> and <xref ref-type="fig" rid="fig4">Figure 4</xref> are summaries. <xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig2">2</xref> and <xref ref-type="fig" rid="fig3">3</xref> contain heat maps that are summaries of the data in the bar charts. <xref ref-type="fig" rid="fig5">Figure 5</xref> is technical description (would be better as supplementary). The data in <xref ref-type="fig" rid="fig1">Figures 1</xref>, <xref ref-type="fig" rid="fig2">2</xref> and <xref ref-type="fig" rid="fig3">3</xref> contain protein secretion data from a multiplex Luminex array – i.e. multiple readouts from a simple experiment but organised into separate figures. All of these data could be condensed and consolidated.</italic> </p><p>We thank the reviewers for highlighting the excessive redundancy in the presentation of our data. We agree with this comment and performed substantial changes aimed at condensing the information presented in the manuscript. Original <xref ref-type="fig" rid="fig4">Figure 4</xref> (radar graph) was removed from the manuscript and we kept only <xref ref-type="table" rid="tbl1">Table 1</xref> as we found it a useful summary of results and experimental conditions. All heat maps were removed from the manuscript. We condensed <xref ref-type="fig" rid="fig3">Figure 3</xref> and Figure 3—figure supplement 1 into one <xref ref-type="fig" rid="fig3">Figure 3</xref>. The technical inset in <xref ref-type="fig" rid="fig5">Figure 5</xref> was moved in a supplemental figure, but we opted for maintaining the experimental design as a main Figure since we believe it could be helpful as further clarification of the experimental parameters and timeline. We also opted for keeping the Luminex data separated into multiple figures since the entire Results section is subdivided according to the main cellular responses rather than the assays performed. We are open to modifying the manuscript structure if the reviewers still feel that this represents a critical issue for the presentation of data.</p><p><italic>5) There is no information on myofibroblast differentiation (e.g. ICC of α-SMA) which would be interesting to know as myofibroblast phenotype is of key importance in regulating ECM turnover and cardiac remodeling.</italic> </p><p>We agree with the reviewers on the importance of myofibroblast differentiation in the context of cardiac injury and remodeling. We therefore performed additional experiments aimed at determining expression and localization of αSMA in CFs cultured in all our combined conditions of oxygen levels and mechanical stimulation. These new results have been added to a new paragraph in Results (paragraph “D. Myofibroblast differentiation”; and new <xref ref-type="fig" rid="fig4">Figure 4</xref> in the revised version) and reveal that a diffuse cytoplasmic αSMA staining is present in CFs cultured under all conditions. The expressed αSMA does not get incorporated into CFs stress fibers, as revealed by actin counterstaining, indicating that the early environmental conditions are not sufficient to induce myofibroblast differentiation per se. In addition, we included positive controls for our stainings (CFs supplemented with high levels of TGF-β, a known inducer of myofibroblast differentiation) that show how CFs exhibit αSMA co-localized with actin stress fibers.</p><p><italic>6) The numbers of cell donors, independent experiments, and biological replicates should be specified for all experimental data.</italic> </p><p>We added this information to each figure caption for all experimental data collected.</p><p><italic>7) The reference list lacks important information (e.g. volume and page numbers).</italic> </p><p>We have fixed the errors in the references.</p></body></sub-article></article>